首页 » 细胞株7-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

细胞株7-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

  • 价  格:¥19200
  • 货  号:Cell Line CV7
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作QQ:1843439339 (微信同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines

BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心


ID   AHH-1

AC   CVCL_3640

SY   AHH1

DR   CLO; CLO_0001688

DR   ATCC; CRL-8146

DR   BioSample; SAMN03471195

RX   Patent=US4532204;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 11,13

ST   D16S539: 10

ST   D5S818: 12,13

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 8,9

ST   vWA: 18,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2710 ! RPMI-1788

SX   Male

CA   Transformed cell line

//

ID   AHL-1

AC   CVCL_4611

SY   AHL 1; AHL1; Armenian Hamster Lung-1

DR   CLO; CLO_0001689

DR   CLDB; cl261

DR   ECACC; 90120504

DR   ATCC; CCL-195

DR   Wikidata; Q18205164

RX   CelloPub=CLPUB00292;

RX   PubMed=7065527;

WW   https://en.wikipedia.org/wiki/AHL-1_cells

CC   Discontinued: ECACC; 90120504; probable.

OX   NCBI_TaxID=10032; ! Cricetulus migratorius

SX   Male

CA   Spontaneously immortalized cell line

//

ID   AI0009

AC   CVCL_8B79

DR   ECACC; 90102303

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AI0249

AC   CVCL_8B80

DR   ECACC; 95031607

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AICHI-4

AC   CVCL_5G39

RX   PubMed=5728341;

CC   Doubling time: ~24 hours (PubMed=5728341).

DI   NCIt; C9357; Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AIG

AC   CVCL_8483

DR   JCRB; JCRB1105

DR   JCRB; NIHS0387

RX   PubMed=1170023;

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

CC   Discontinued: JCRB; NIHS0387; true.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0212 ! CHL

SX   Female

CA   Transformed cell line

//

ID   AIK-T4

AC   CVCL_1B42

DR   ChEMBL-Cells; CHEMBL3307276

DR   ChEMBL-Targets; CHEMBL614024

RX   PubMed=8608235;

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1B43 ! AIK-T8

SX   Female

CA   Transformed cell line

//

ID   AIK-T8

AC   CVCL_1B43

DR   ChEMBL-Cells; CHEMBL3308406

DR   ChEMBL-Targets; CHEMBL613504

RX   PubMed=8608235;

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1B42 ! AIK-T4

SX   Female

CA   Transformed cell line

//

ID   AILNCaP

AC   CVCL_U984

SY   AI LNCaP; AI-LNCaP; Androgen-Independent LNCaP

DR   BTO; BTO:0004799

RX   PubMed=16931574;

CC   Derived from metastatic site: Left supraclavicular lymph node.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0395 ! LNCaP

SX   Male

CA   Cancer cell line

//

ID   Ainv15

AC   CVCL_6563

SY   AinV15; Ain V15

DR   CLO; CLO_0001690

DR   ATCC; SCRC-1029

RX   PubMed=11955444;

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Discontinued: ATCC; SCRC-1029; true.

CC   Breed/subspecies: 129/Ola.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_X727 ! E14-nlsrtTA-7

SX   Male

CA   Embryonic stem cell

//

ID   Ainv18

AC   CVCL_2G81

SY   AinV18; Ain V18; Ainv-18; Ainv 18

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Breed/subspecies: 129/Ola.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_X727 ! E14-nlsrtTA-7

SX   Male

CA   Embryonic stem cell

//

ID   aIR-1

AC   CVCL_K040

SY   anti-IR-1; alpha IR-1

DR   CLO; CLO_0009734

DR   ATCC; HB-175

RX   PubMed=6304046;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6972 ! FO [Mouse myeloma]

CA   Hybridoma

//

ID   aIR-2

AC   CVCL_K041

SY   anti-IR-2; alpha IR-2

RX   PubMed=6304046;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6972 ! FO [Mouse myeloma]

CA   Hybridoma

//

ID   aIR-3

AC   CVCL_K042

SY   anti-IR-3; alpha IR-3

RX   PubMed=6304046;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6972 ! FO [Mouse myeloma]

CA   Hybridoma

//

ID   AJ8

AC   CVCL_N321

DR   ATCC; HB-8339

RX   Patent=US4935344;

CC   Discontinued: ATCC; HB-8339; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   AK-D

AC   CVCL_3641

SY   AKD

DR   CLO; CLO_0001692

DR   CLDB; cl263

DR   CLDB; cl5135

DR   ATCC; CCL-150

DR   ECACC; 89071903

RX   PubMed=1271751;

RX   PubMed=7065527;

OX   NCBI_TaxID=9685; ! Felis catus

CA   Spontaneously immortalized cell line

//

ID   AK778

AC   CVCL_W745

SY   AK 778

RX   PubMed=1325212;

RX   PubMed=3080238;

RX   PubMed=6286763;

RX   PubMed=7757991;

RX   PubMed=8515068;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Akata

AC   CVCL_0148

SY   AKATA; Akata-BL; Akata BL

DR   MCCL; MCC:0000041

DR   Cosmic; 931094

DR   Cosmic; 2301567

DR   NCBI_Iran; C451

DR   TOKU-E; 3580

RX   PubMed=1647567;

RX   PubMed=1915267;

RX   PubMed=9473234;

RX   PubMed=9973220;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Akata 2A8

AC   CVCL_6247

SY   2A8

DR   Lonza; 137

RX   PubMed=9593003;

RX   PubMed=10022853;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Characteristics: EBV-negative. Treated with hydroxyurea which completely eliminated EBV episomes.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Protein expression by reverse-phase protein arrays.

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0148 ! Akata

SX   Female

CA   Cancer cell line

//

ID   Akata 2C1

AC   CVCL_6248

SY   2C1

RX   PubMed=9593003;

RX   PubMed=10022853;

CC   Characteristics: EBV-negative. Treated with hydroxyurea which completely eliminated EBV episomes.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0148 ! Akata

SX   Female

CA   Cancer cell line

//

ID   Akata 3F2

AC   CVCL_6249

SY   3F2

RX   PubMed=9593003;

RX   PubMed=10022853;

CC   Characteristics: EBV-negative. Treated with hydroxyurea which completely eliminated EBV episomes.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0148 ! Akata

SX   Female

CA   Cancer cell line

//

ID   Akata EG

AC   CVCL_6250

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0148 ! Akata

SX   Female

CA   Cancer cell line

//

ID   AKH12

AC   CVCL_0C56

DR   TOKU-E; 3989

RX   PubMed=16809312;

CC   From: Eisenbauer A.; Institute of Cancer Research of the Medical University of Vienna; Vienna; Austria.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   AKH13

AC   CVCL_0C57

DR   Cosmic; 2162535

DR   TOKU-E; 3990

RX   PubMed=16809312;

RX   PubMed=23887712;

CC   From: Eisenbauer A.; Institute of Cancer Research of the Medical University of Vienna; Vienna; Austria.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   AKI

AC   CVCL_8170

DR   BioSample; SAMN03151663

DR   RCB; RCB0408

RX   PubMed=3145150;

RX   PubMed=16643607;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=16643607, PubMed=20143388). Originally thought to originate from a melanoma in a male patient.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Discontinued: RCB; RCB0408; true.

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   AKIBA

AC   CVCL_E453

DR   dbMHC; 48471

DR   ECACC; 94022520

DR   IHW; IHW9286

DR   IMGT/HLA; 10239

RX   PubMed=16702430;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl286.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AKR-2B

AC   CVCL_4103

SY   AKR mouse embryo cells clone 2B

DR   CLO; CLO_0001701

DR   CLDB; cl264

DR   ECACC; 91061307

DR   TOKU-E; 4150

RX   PubMed=196768;

RX   PubMed=679187;

RX   PubMed=2706619;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=AKR-2B

CC   Breed/subspecies: AKR.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   AKR-MCA

AC   CVCL_Y466

RX   PubMed=196768;

RX   PubMed=679187;

RX   PubMed=2706619;

RX   PubMed=6265069;

CC   Breed/subspecies: AKR.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4103 ! AKR-2B

CA   Transformed cell line

//

ID   AKR/11D

AC   CVCL_3341

SY   AKR/11-D; 11D12

DR   CLO; CLO_0001693

DR   CLDB; cl4924

DR   ICLC; ATL98007

RX   PubMed=1401954;

RX   PubMed=7517914;

CC   Transformant: NCIt; C17262; X-Ray.

CC   Breed/subspecies: AKR/J.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26

CA   Cancer cell line

//

ID   AKR/12B-1

AC   CVCL_3342

DR   CLO; CLO_0001694

DR   CLDB; cl4939

DR   ICLC; ATL98005

RX   PubMed=1401954;

RX   PubMed=7517914;

CC   Transformant: NCIt; C17262; X-Ray.

CC   Breed/subspecies: AKR/J.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26

CA   Cancer cell line

//

ID   AKR/12B-2

AC   CVCL_3343

DR   CLO; CLO_0001695

DR   CLDB; cl4925

DR   ICLC; ATL98008

RX   PubMed=1401954;

RX   PubMed=7517914;

CC   Transformant: NCIt; C17262; X-Ray.

CC   Breed/subspecies: AKR/J.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26

CA   Cancer cell line

//

ID   AKR/12B-3

AC   CVCL_3344

DR   CLO; CLO_0001696

DR   CLDB; cl4926

DR   ICLC; ATL98009

RX   PubMed=1401954;

RX   PubMed=7517914;

CC   Transformant: NCIt; C17262; X-Ray.

CC   Breed/subspecies: AKR/J.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26

CA   Cancer cell line

//

ID   AKR/13B

AC   CVCL_3345

DR   CLO; CLO_0001697

DR   CLDB; cl4927

DR   ICLC; ATL98006

RX   PubMed=1401954;

RX   PubMed=7517914;

CC   Transformant: NCIt; C17262; X-Ray.

CC   Breed/subspecies: AKR/J.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26

CA   Cancer cell line

//

ID   AKR/14C

AC   CVCL_3346

SY   14C6

DR   CLO; CLO_0001698

DR   CLDB; cl4928

DR   ICLC; ATL98010

RX   PubMed=1401954;

RX   PubMed=7517914;

CC   Transformant: NCIt; C17262; X-Ray.

CC   Breed/subspecies: AKR/J.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6565 ! AKR1.G.1.OUAR.1.26

CA   Cancer cell line

//

ID   AKR/JA.Sp

AC   CVCL_6564

DR   CLO; CLO_0001699

DR   ATCC; CRL-6320

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6320; true.

CC   Breed/subspecies: AKR/J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Finite cell line

//

ID   AKR/JB.Sp

AC   CVCL_S401

DR   ATCC; CRL-6321

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6321; true.

CC   Breed/subspecies: AKR/J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Finite cell line

//

ID   AKR1.G.1.OUAR.1.26

AC   CVCL_6565

SY   AKR1.G.1.OVAR.1.26; AKR1(Thy-1-a) TGr; AKR1; AKR/1

DR   CLO; CLO_0001700

DR   ATCC; TIB-232

RX   DOI=10.1007/BF01561574;

CC   Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.

CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).

CC   Breed/subspecies: AKR/J.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   Akuba

AC   CVCL_W933

SY   AKUBA

DR   Cosmic; 931113

RX   PubMed=170370;

RX   PubMed=4122458;

RX   PubMed=4364259;

RX   PubMed=7316467;

RX   PubMed=9473234;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   AL 1-27

AC   CVCL_J741

SY   A 127; A127; M-11

DR   CLO; CLO_0001702

DR   ATCC; HB-8441

RX   Patent=US4806628;

RX   Patent=US4808704;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Al Ke

AC   CVCL_3642

DR   CLO; CLO_0001703

DR   ATCC; CRL-1325

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   Al Pos

AC   CVCL_4J63

DR   ATCC; CRL-1120

CC   Discontinued: ATCC; CRL-1120; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   AL-3-11A

AC   CVCL_DE34

RX   PubMed=20020445;

CC   Transformant: Ad5-SV40.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AL-4-17

AC   CVCL_DE35

RX   PubMed=20020445;

CC   Transformant: Ad5-SV40.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AL/N

AC   CVCL_6312

SY   N AL/N

DR   CLO; CLO_0001704

DR   ATCC; CRL-6506

RX   PubMed=4302577;

RX   PubMed=4331720;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6506; true.

CC   Breed/subspecies: AL/N.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   AL1

AC   CVCL_X931

SY   AL-1

DR   CGH-DB; 9189-4

RX   PubMed=4321974;

RX   PubMed=5902320;

CC   Characteristics: EBV-negative.

DI   NCIt; C2912; Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ALA

AC   CVCL_J358

SY   Ala; HCT-ALA

DR   Cosmic; 711270

DR   Cosmic; 887234

DR   Cosmic; 1479575

RX   PubMed=3349466;

RX   PubMed=7329817;

RX   PubMed=9000147;

RX   PubMed=9000572;

RX   PubMed=11526487;

CC   Microsatellite instability: Stable (MSS) (PubMed=9000147).

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   AlAb

AC   CVCL_U957

SY   ALAB; Alab; A1Ab

DR   ATCC; CRL-7715

DR   Cosmic; 1218871

DR   GEO; GSM783944

RX   PubMed=212193;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=6582512;

RX   PubMed=6935474;

RX   PubMed=7459858;

RX   PubMed=14490970;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-7715; true.

CC   Derived from metastatic site: Lung.

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ALBA

AC   CVCL_F698

DR   IMGT/HLA; 12067

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ALC [Mouse ameloblast]

AC   CVCL_1947

SY   Ameloblast-Lineage Cells

RX   PubMed=12927794;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   ALC [Mouse bone marrow]

AC   CVCL_0E84

RX   PubMed=2435412;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Stromal cell line

//

ID   ALF

AC   CVCL_M035

RX   PubMed=15767549;

CC   Part of: JFCR45 cancer cell line panel.

CC   Miscellaneous: Only mentioned as a stomach cancer cell line in PubMed=15767549.

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ali-BL

AC   CVCL_7172

SY   Ali

RX   PubMed=9882297;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ALKO

AC   CVCL_5I28

SY   Astrocyte LKB1 knock out

WW   https://www.kerafast.com/product/2226/astrocyte-lkb1-knock-out-cell-line-alko

CC   Doubling time: 18-24 hours (Kerafast).

CC   Knockout cell: Method=Homologous recombination; MGI; MGI:1341870; Stk11.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   ALL-7031-B

AC   CVCL_0B39

SY   7031-B

RX   PubMed=3495441;

DI   NCIt; C3262; Neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ALL-PO

AC   CVCL_1069

DR   CLO; CLO_0001705

DR   CLDB; cl5399

DR   ChEMBL-Cells; CHEMBL3308227

DR   ChEMBL-Targets; CHEMBL2366294

DR   Cosmic; 910944

DR   Cosmic-CLP; 910944

DR   GDSC; 910944

DR   GEO; GSM1669596

DR   ICLC; HTL01003

RX   PubMed=9444945;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; ICLC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 13

ST   D21S11: 29,30

ST   D5S818: 11,12

ST   D7S820: 9,11

ST   TH01: 6,7

ST   TPOX: 8,9

ST   vWA: 16,17

DI   NCIt; C80342; B acute lymphoblastic leukemia with t(v;11q23) MLL rearranged

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ALL-SIL

AC   CVCL_1805

SY   ALLSIL; SIL-ALL

DR   BTO; BTO:0005360

DR   BioSample; SAMN03473514

DR   CCLE; ALLSIL_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 721715

DR   Cosmic; 913404

DR   Cosmic; 933537

DR   Cosmic; 996306

DR   Cosmic; 998724

DR   Cosmic; 1037687

DR   Cosmic; 1115585

DR   Cosmic; 1175126

DR   Cosmic; 1224372

DR   Cosmic; 1330498

DR   Cosmic; 1524789

DR   Cosmic; 1641391

DR   Cosmic; 1664519

DR   Cosmic; 1760517

DR   Cosmic; 2165718

DR   Cosmic-CLP; 1295740

DR   DSMZ; ACC-511

DR   GDSC; 1295740

DR   GEO; GSM1669597

RX   PubMed=10071127;

RX   PubMed=17117183;

RX   PubMed=22675565;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~48 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Misspelling: 'AL:L-SIL' in Cosmic 913404.

ST   Source(s): Cosmic-CLP; DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9,12

ST   D16S539: 10,12

ST   D5S818: 11,13

ST   D7S820: 11,12

ST   TH01: 7,9.3

ST   TPOX: 10,11

ST   vWA: 17

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ALL/MIK

AC   CVCL_W883

RX   PubMed=8167560;

DI   NCIt; C36312; B acute lymphoblastic leukemia with t(9;22)(q34;q11.2) BCR-ABL1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AllSi-Heart

AC   CVCL_DA19

RX   DOI=10.1007/s11434-011-4622-9;

CC   Group: Reptilian cell line.

CC   Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the species and the name of the tissue.

OX   NCBI_TaxID=38654; ! Alligator sinensis

OI   CVCL_DA20 ! AllSi-Liver

OI   CVCL_DA21 ! AllSi-Muscle

SX   Sex undetermined

CA   Finite cell line

//

ID   AllSi-Liver

AC   CVCL_DA20

RX   DOI=10.1007/s11434-011-4622-9;

CC   Group: Reptilian cell line.

CC   Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the species and the name of the tissue.

OX   NCBI_TaxID=38654; ! Alligator sinensis

OI   CVCL_DA19 ! AllSi-Heart

OI   CVCL_DA21 ! AllSi-Muscle

SX   Sex undetermined

CA   Finite cell line

//

ID   AllSi-Muscle

AC   CVCL_DA21

RX   DOI=10.1007/s11434-011-4622-9;

CC   Group: Reptilian cell line.

CC   Miscellaneous: As no cell line name was given in the paper, we assigned the name based on the abbreviation of the species and the name of the tissue.

OX   NCBI_TaxID=38654; ! Alligator sinensis

OI   CVCL_DA19 ! AllSi-Heart

OI   CVCL_DA20 ! AllSi-Liver

SX   Sex undetermined

CA   Finite cell line

//

ID   ALMC-1

AC   CVCL_M525

RX   CelloPub=CLPUB00252;

RX   PubMed=18567838;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M526 ! ALMC-2

SX   Female

CA   Cancer cell line

//

ID   ALMC-2

AC   CVCL_M526

RX   CelloPub=CLPUB00252;

RX   PubMed=18567838;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M525 ! ALMC-1

SX   Female

CA   Cancer cell line

//

ID   alpha-ACE 3.1.1

AC   CVCL_K122

SY   ACE 3.1.1; a-ACE 3.1.1

DR   CLO; CLO_0009730

DR   ATCC; HB-8191

RX   Patent=US4582790;

RX   PubMed=6296854;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   alpha T1

AC   CVCL_AW09

RX   PubMed=2562221;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   alpha T2

AC   CVCL_AW10

SY   alphaT2

RX   PubMed=1694016;

RX   PubMed=2562221;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   Alpha-TSH

AC   CVCL_U364

SY   alpha TSH

RX   PubMed=1704102;

RX   PubMed=15541569;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   alphaPIG-AT25-miPSC

AC   CVCL_IS70

RX   PubMed=27879210;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transfected with: UniProtKB; P13249; S.alboniger pac.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Breed/subspecies: C57BL/6 x 129S4/SvJae.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_IS69 ! TiB7-4

CA   Induced pluripotent stem cell

//

ID   AlphaT1-1

AC   CVCL_U463

SY   Alpha-T1-1

RX   PubMed=8898243;

RX   PubMed=15541569;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6 x BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_U355 ! TalphaT1

CA   Transformed cell line

//

ID   AlphaT3-1

AC   CVCL_0149

SY   AlphaT31; alphaT3-1; alpha T3-1; alpha-T3-1

DR   BTO; BTO:0003566

DR   MCCL; MCC:0000042

RX   PubMed=1704103;

RX   PubMed=8898243;

RX   PubMed=15541569;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6 x BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   alphaTC1

AC   CVCL_B035

SY   alpha-TC1; alpha TC1; aTC1

RX   PubMed=2156740;

CC   Breed/subspecies: C57BL/6 x DBA/2.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   alphaTC1 Clone 6

AC   CVCL_B036

SY   alpha TC1 clone 6; alphaTC clone 6; alpha-TC1.6; alpha-TC1-6; alpha TC1-6; alpha TC1.6; aTC1 Clone 6; aTC1-6

DR   BTO; BTO:0002982

DR   ATCC; CRL-2934

DR   TOKU-E; 4124

RX   PubMed=2108069;

CC   Breed/subspecies: C57BL/6 x DBA/2.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B035 ! alphaTC1

CA   Cancer cell line

//

ID   alphaTC1 Clone 9

AC   CVCL_0150

SY   alpha TC1 clone 9; alphaTC clone 9; alpha-TC1.9; alpha-TC1-9; aTC1 Clone 9; aTC1-9

DR   BTO; BTO:0002981

DR   CLO; CLO_0009736

DR   MCCL; MCC:0000495

DR   ATCC; CRL-2350

RX   PubMed=2108069;

CC   Breed/subspecies: C57BL/6 x DBA/2.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B035 ! alphaTC1

CA   Cancer cell line

//

ID   alphaTN4

AC   CVCL_AW08

RX   PubMed=1694016;

RX   PubMed=2178867;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_AW10 ! alpha T2

CA   Transformed cell line

//

ID   alphaTN4-1

AC   CVCL_D858

SY   alpha TN4-1

DR   BTO; BTO:0001872

RX   PubMed=1694016;

RX   PubMed=9990330;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_AW08 ! alphaTN4

CA   Transformed cell line

//

ID   alphaTN6

AC   CVCL_AW11

RX   PubMed=1694016;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_AW10 ! alpha T2

CA   Transformed cell line

//

ID   ALS-iPS1

AC   CVCL_L641

DR   ISCR; 1961

RX   PubMed=22673189;

CC   From: Guangzhou Medical College; China.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L642 ! ALS-iPS2

SX   Male

CA   Induced pluripotent stem cell

//

ID   ALS-iPS2

AC   CVCL_L642

DR   ISCR; 1962

RX   PubMed=22673189;

CC   From: Guangzhou Medical College; China.

DI   NCIt; C34373; Amyotrophic lateral sclerosis

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_L641 ! ALS-iPS1

SX   Male

CA   Induced pluripotent stem cell

//

ID   ALST

AC   CVCL_W778

RX   PubMed=10972993;

RX   PubMed=11793438;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ALT

AC   CVCL_Y087

DR   BCRC; 60581

RX   PubMed=21894147;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   ALT-F

AC   CVCL_B328

SY   ALTF

DR   Cosmic; 889538

RX   PubMed=7960578;

RX   PubMed=11964082;

CC   Derived from metastatic site: Liver.

DI   NCIt; C2955; Colorectal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B329 ! ALT-G

OI   CVCL_B330 ! ALT-I

CA   Cancer cell line

//

ID   ALT-G

AC   CVCL_B329

SY   ALTG

DR   Cosmic; 889539

RX   PubMed=7960578;

RX   PubMed=11964082;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C2955; Colorectal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B328 ! ALT-F

OI   CVCL_B330 ! ALT-I

CA   Cancer cell line

//

ID   ALT-I

AC   CVCL_B330

SY   ALTI

DR   Cosmic; 889537

DR   Cosmic; 902792

RX   PubMed=7960578;

RX   PubMed=11964082;

DI   NCIt; C2955; Colorectal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B328 ! ALT-F

OI   CVCL_B329 ! ALT-G

CA   Cancer cell line

//

ID   ALTS1C1

AC   CVCL_Y088

DR   BCRC; 60582

RX   PubMed=21894147;

CC   Breed/subspecies: C57BL/6J.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_Y087 ! ALT

SX   Male

CA   Transformed cell line

//

ID   ALTS1C1-SDFkd

AC   CVCL_GT22

SY   ALTS1C1 (SDFkd)

DR   BCRC; 60608

RX   PubMed=21894147;

CC   Knockout cell: Method=siRNA knockdown; MGI; MGI:103556; Cxcl12.

CC   Breed/subspecies: C57BL/6J.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_Y088 ! ALTS1C1

SX   Male

CA   Transformed cell line

//

ID   ALVA-101

AC   CVCL_4735

SY   ALVA 101; ALVA101; American Lake VA-101

DR   BioSample; SAMN03151888

RX   PubMed=1958578;

RX   PubMed=8561862;

RX   PubMed=9018337;

RX   PubMed=12725112;

RX   PubMed=14518029;

RX   PubMed=20143388;

WW   http://capcelllines.ca/details.asp?id=170

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=14518029, PubMed=20143388).

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   ALVA-31

AC   CVCL_4737

SY   ALVA 31; ALVA31; American Lake VA-31

DR   BTO; BTO:0003850

DR   BioSample; SAMN03151889

RX   PubMed=7681207;

RX   PubMed=8561862;

RX   PubMed=12725112;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   ALVA-38

AC   CVCL_Y656

SY   ALVA38; American Lake VA-38

RX   PubMed=8561862;

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ALVA-41

AC   CVCL_4734

SY   ALVA 41; ALVA41; American Lake VA-41

DR   BTO; BTO:0002006

DR   BioSample; SAMN03151890

RX   PubMed=1958578;

RX   PubMed=7533340;

RX   PubMed=8561862;

RX   PubMed=12725112;

RX   PubMed=20143388;

WW   http://capcelllines.ca/details.asp?id=84

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=20143388).

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   ALVA-55

AC   CVCL_4736

SY   ALVA55; American Lake VA-55

DR   BioSample; SAMN03151891

RX   PubMed=8561862;

RX   PubMed=14518029;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=14518029, PubMed=20143388).

CC   Derived from metastatic site: Bone.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0035 ! PC-3

SX   Male

CA   Cancer cell line

//

ID   ALZ.1

AC   CVCL_W671

DR   IZSLER; BS ALZ 1

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.10

AC   CVCL_W679

DR   IZSLER; BS ALZ 10

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.11

AC   CVCL_W680

DR   IZSLER; BS ALZ 11

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.12

AC   CVCL_W681

DR   IZSLER; BS ALZ 12

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.13

AC   CVCL_W682

DR   IZSLER; BS ALZ 13

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.14

AC   CVCL_W683

DR   IZSLER; BS ALZ 14

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.15

AC   CVCL_W684

DR   IZSLER; BS ALZ 15

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.16

AC   CVCL_W685

DR   IZSLER; BS ALZ 16

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.17

AC   CVCL_W686

DR   IZSLER; BS ALZ 17

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.18

AC   CVCL_W687

DR   IZSLER; BS ALZ 18

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.19

AC   CVCL_W688

DR   IZSLER; BS ALZ 19

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.2

AC   CVCL_W672

DR   IZSLER; BS ALZ 2

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.20

AC   CVCL_W689

DR   IZSLER; BS ALZ 20

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.21

AC   CVCL_W690

DR   IZSLER; BS ALZ 21

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.22

AC   CVCL_W691

DR   IZSLER; BS ALZ 22

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.23

AC   CVCL_W692

DR   IZSLER; BS ALZ 23

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.24

AC   CVCL_W693

DR   IZSLER; BS ALZ 24

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.25

AC   CVCL_W694

DR   IZSLER; BS ALZ 25

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.26

AC   CVCL_W695

DR   IZSLER; BS ALZ 26

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.27

AC   CVCL_W696

DR   IZSLER; BS ALZ 27

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.28

AC   CVCL_W697

DR   IZSLER; BS ALZ 28

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.29

AC   CVCL_W698

DR   IZSLER; BS ALZ 29

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.3

AC   CVCL_W673

DR   IZSLER; BS ALZ 3

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.30

AC   CVCL_W699

DR   IZSLER; BS ALZ 30

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.31

AC   CVCL_W700

DR   IZSLER; BS ALZ 31

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.32

AC   CVCL_W701

DR   IZSLER; BS ALZ 32

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.33

AC   CVCL_W702

DR   IZSLER; BS ALZ 33

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.34

AC   CVCL_W703

DR   IZSLER; BS ALZ 34

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.35

AC   CVCL_W704

DR   IZSLER; BS ALZ 35

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.38

AC   CVCL_W705

DR   IZSLER; BS ALZ 38

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.39

AC   CVCL_W706

DR   IZSLER; BS ALZ 39

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.4

AC   CVCL_W674

DR   IZSLER; BS ALZ 4

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.40

AC   CVCL_W707

DR   IZSLER; BS ALZ 40

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.41

AC   CVCL_W708

DR   IZSLER; BS ALZ 41

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.42

AC   CVCL_W709

DR   IZSLER; BS ALZ 42

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.43

AC   CVCL_W710

DR   IZSLER; BS ALZ 43

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.44

AC   CVCL_W711

DR   IZSLER; BS ALZ 44

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.5

AC   CVCL_W675

DR   IZSLER; BS ALZ 5

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.6

AC   CVCL_W676

DR   IZSLER; BS ALZ 6

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.7

AC   CVCL_W677

DR   IZSLER; BS ALZ 7

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   ALZ.9

AC   CVCL_W678

DR   IZSLER; BS ALZ 9

DI   NCIt; C2866; Alzheimer's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   AM

AC   CVCL_E454

SY   AMR

DR   dbMHC; 48472

DR   ECACC; 94022521

DR   IHW; IHW9206

DR   IMGT/HLA; 10244

WW   http://bioinformatics.hsanmartino.it/ecbr/cl206.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ECACC; 94022521; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Am Coo

AC   CVCL_3306

DR   CLO; CLO_0001707

DR   ATCC; CRL-1286

DI   NCIt; C26837; Osteogenesis imperfecta

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Am II

AC   CVCL_HF26

SY   AM II; AmII

RX   PubMed=516912;

OX   NCBI_TaxID=9823; ! Sus scrofa

CA   Spontaneously immortalized cell line

//

ID   Am Ric

AC   CVCL_3307

DR   CLO; CLO_0001708

DR   ATCC; CRL-1129

DI   NCIt; C26837; Osteogenesis imperfecta

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Am Tim

AC   CVCL_U765

DR   ATCC; CRL-1270

CC   Discontinued: ATCC; CRL-1270; true.

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   AM-1

AC   CVCL_4Z40

DR   Cosmic; 2163016

DR   Cosmic; 2209114

RX   PubMed=9682983;

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

DI   NCIt; C4313; Ameloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AM-38

AC   CVCL_1070

SY   AM38; AM

DR   BioSample; SAMN03470932

DR   CCLE; AM38_CENTRAL_NERVOUS_SYSTEM

DR   CGH-DB; 139-1

DR   ChEMBL-Cells; CHEMBL3308829

DR   ChEMBL-Targets; CHEMBL2366192

DR   Cosmic; 685873

DR   Cosmic; 910933

DR   Cosmic; 1746962

DR   Cosmic; 2302334

DR   Cosmic; 2367507

DR   Cosmic; 2516013

DR   Cosmic-CLP; 910933

DR   GDSC; 910933

DR   GEO; GSM326247

DR   GEO; GSM886866

DR   GEO; GSM887931

DR   GEO; GSM1669598

DR   IFO; IFO50492

RX   PubMed=7947440;

RX   PubMed=8145054;

RX   PubMed=16232199;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 72 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8

ST   D16S539: 11,13

ST   D18S51: 13

ST   D19S433: 14

ST   D21S11: 30

ST   D2S1338: 19,24

ST   D3S1358: 15

ST   D5S818: 12,13

ST   D7S820: 12

ST   D8S1179: 13,14

ST   FGA: 23,25

ST   Penta D: 13

ST   Penta E: 5,18

ST   TH01: 7

ST   TPOX: 11

ST   vWA: 17,18 (Cosmic-CLP)

ST   vWA: 17 (JCRB; PubMed=25877200)

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AM-C6SC8

AC   CVCL_1948

SY   AMC6SC8; AMc6sc8

DR   CLO; CLO_0001712

DR   CLDB; cl266

DR   DSMZ; ACC-152

RX   DOI=10.1007/BF03191992;

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_HF26 ! Am II

CA   Spontaneously immortalized cell line

//

ID   AM-HLH

AC   CVCL_IP72

RX   PubMed=27813134;

CC   Characteristics: Contains multiple intergrated copies of the EBV genome.

CC   Doubling time: 35-40 hours (PubMed=27813134).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C9357; Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AM-iPS-1

AC   CVCL_D904

SY   Mint; AM-iPS-01

DR   SKIP; SKIP000365

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-10

AC   CVCL_D905

SY   Angelica

DR   SKIP; SKIP000370

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-11

AC   CVCL_D906

SY   Oregano

DR   SKIP; SKIP000371

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-12

AC   CVCL_D907

SY   Fennel

DR   SKIP; SKIP000372

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-13

AC   CVCL_D908

SY   Basil

DR   SKIP; SKIP000363

RX   PubMed=21155951;

RX   PubMed=21637780;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-15

AC   CVCL_D909

SY   Anise

DR   SKIP; SKIP000373

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-16

AC   CVCL_D910

SY   Parsley

DR   SKIP; SKIP000374

RX   PubMed=21155951;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-17

AC   CVCL_D911

SY   Myrtle

DR   SKIP; SKIP000375

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-18

AC   CVCL_D912

SY   Savory

DR   SKIP; SKIP000376

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-19

AC   CVCL_D913

SY   Chamomile

DR   SKIP; SKIP000377

RX   PubMed=21155951;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-2

AC   CVCL_D914

SY   Clary; AM-iPS-02

DR   SKIP; SKIP000366

RX   PubMed=23631808;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-20

AC   CVCL_D915

SY   Lovage

DR   SKIP; SKIP000364

RX   PubMed=21155951;

RX   PubMed=21637780;

RX   PubMed=23631808;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-3

AC   CVCL_D916

SY   Sage; AM-iPS-03

DR   SKIP; SKIP000359

RX   PubMed=21155951;

RX   PubMed=21637780;

RX   PubMed=23631808;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-4

AC   CVCL_D917

SY   Laurier; AM-iPS-04

DR   SKIP; SKIP000367

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-5

AC   CVCL_D918

SY   Chives; AM-iPS-05

DR   SKIP; SKIP000360

RX   PubMed=21155951;

RX   PubMed=21637780;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-6

AC   CVCL_D919

SY   Hyssop; AM-iPS-06

DR   SKIP; SKIP000361

RX   PubMed=21637780;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-7

AC   CVCL_D920

SY   Marry; AM-iPS-07

DR   SKIP; SKIP000368

RX   PubMed=23631808;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-8

AC   CVCL_D921

SY   Thyme; AM-iPS-08

DR   SKIP; SKIP000362

RX   PubMed=21155951;

RX   PubMed=21637780;

RX   PubMed=23631808;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM-iPS-9

AC   CVCL_D922

SY   Sorrel; AM-iPS-09

DR   SKIP; SKIP000369

RX   PubMed=21155951;

WW   http://nrichd.ncchd.go.jp/reproduction/hipscell.htm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_D691 ! AM936EP

SX   Female

CA   Induced pluripotent stem cell

//

ID   AM0249

AC   CVCL_8B81

DR   ECACC; 92060801

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C34368; Alpha thalassemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   Am1010

AC   CVCL_W188

RX   PubMed=20418894;

CC   Derived from metastatic site: Upper arm muscle.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   aM346C7C1

AC   CVCL_K043

SY   alphaM346C7C1; anti M346C7C1

DR   CLO; CLO_0009735

DR   ATCC; HB-11124

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   AM936EP

AC   CVCL_D691

RX   PubMed=21155951;

RX   PubMed=21637780;

RX   PubMed=23631808;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   AMAI

AC   CVCL_E455

SY   AMAL

DR   dbMHC; 48473

DR   ECACC; 94070701

DR   IHW; IHW9010

DR   IMGT/HLA; 10246

WW   http://bioinformatics.hsanmartino.it/ecbr/cl10.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AMALA

AC   CVCL_E456

SY   AZL

DR   CLDB; cl7225

DR   dbMHC; 48474

DR   ECACC; 88052064

DR   ICLC; HTL14002

DR   IHW; IHW9064

DR   IMGT/HLA; 10247

DR   PRIDE; PXD001205

RX   PubMed=7652742;

RX   PubMed=8307784;

RX   PubMed=25502872;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl64.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: HLA class II peptidome analysis by proteomics.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AMC-106

AC   CVCL_9477

SY   AMC106

DR   Cosmic; 1109110

DR   Cosmic; 1543773

DR   GEO; GSM692873

RX   PubMed=7838528;

RX   PubMed=22213050;

CC   Omics: Transcriptome analysis.

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   AMC-60-TC

AC   CVCL_F917

SY   AMC-60

DR   TKG; TKG 0114

DR   TKG; TKG 0647

CC   Breed/subspecies: ACI/N.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   AMC-hES1

AC   CVCL_B524

DR   ISCR; 1081

RX   PubMed=18033671;

CC   From: Asan Medical Center; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   AMC-hES2

AC   CVCL_B525

DR   ISCR; 1082

RX   PubMed=18033671;

CC   From: Asan Medical Center; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   AMC-HN-1

AC   CVCL_5959

SY   Amc-HN-1

RX   PubMed=9349880;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AMC-HN-2

AC   CVCL_5960

SY   Amc-HN-2

RX   PubMed=9349880;

DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AMC-HN-3

AC   CVCL_5961

SY   Amc-HN-3

RX   PubMed=9349880;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AMC-HN-4

AC   CVCL_5962

SY   Amc-HN-4

RX   PubMed=9349880;

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AMC-HN-5

AC   CVCL_5963

SY   Amc-HN-5

RX   PubMed=9349880;

DI   NCIt; C8192; Nasal cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AMC-HN-6

AC   CVCL_5964

SY   Amc-HN-6

RX   PubMed=9349880;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AMC-HN-7

AC   CVCL_5965

SY   Amc-HN-7

RX   PubMed=9349880;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AMC-HN-8

AC   CVCL_5966

SY   Amc-HN-8

RX   PubMed=9349880;

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AMC-HN-9

AC   CVCL_5967

SY   Amc-HN-9

RX   PubMed=9349880;

RX   PubMed=11039880;

DI   NCIt; C5938; Parotid gland mucoepidermoid carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Amdur II

AC   CVCL_3643

AS   CVCL_AW71

SY   AmdurII; AMDURII; GM00050; GM-50

DR   CLO; CLO_0001713

DR   CLO; CLO_0025172

DR   CLDB; cl270

DR   CLDB; cl271

DR   ATCC; CCL-124

DR   BioSample; SAMN03151822

DR   BioSample; SAMN03472704

DR   Coriell; GM00050

DR   ECACC; 90112605

DR   IZSLER; BS CL 2

DR   KCLB; 10124

RX   CelloPub=CLPUB00290;

RX   PubMed=5788784;

RX   PubMed=14505435;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Partially contaminated. Some stocks were contaminated by pig LLC-PK1 (PubMed=14505435, PubMed=20143388).

CC   Discontinued: ECACC; 90112605; true.

CC   Discontinued: KCLB; 10124; probable.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 10,11

ST   D16S539: 9,12

ST   D5S818: 9,13

ST   D7S820: 9,12

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C98986; Methylmalonic acidemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   AmE-711

AC   CVCL_2H47

SY   AME-711

RX   PubMed=23894551;

WW   https://beeinformed.org/2013/11/18/new-cell-cultures-advance-honey-bee-science/

CC   Group: Insect cell line.

CC   Doubling time: ~4 days (PubMed=23894551).

OX   NCBI_TaxID=7460; ! Apis mellifera

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   AMI005AN

AC   CVCL_F547

SY   TER202; TER271

DR   IMGT/HLA; 11803

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AMJ13

AC   CVCL_4U92

RX   PubMed=26300657;

CC   Doubling time: 22 hours (PubMed=26300657).

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AMJ2-C10

AC   CVCL_0P77

RX   PubMed=1879973;

CC   Transformant: Recombinant retrovirus J2.

CC   Breed/subspecies: C57BL/6J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   AMJ2-C11

AC   CVCL_5913

DR   CLO; CLO_0001714

DR   ATCC; CRL-2456

DR   BCRJ; 0039

RX   PubMed=1879973;

CC   Transformant: Recombinant retrovirus J2.

CC   Breed/subspecies: C57BL/6J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   AMJ2-C20

AC   CVCL_0P78

RX   PubMed=1879973;

CC   Transformant: Recombinant retrovirus J2.

CC   Breed/subspecies: C57BL/6J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   AMJ2-C8

AC   CVCL_5914

DR   CLO; CLO_0001715

DR   ATCC; CRL-2455

RX   PubMed=1879973;

CC   Transformant: Recombinant retrovirus J2.

CC   Breed/subspecies: C57BL/6J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   AML-1

AC   CVCL_S481

RX   PubMed=3496132;

DI   NCIt; C9160; Childhood acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AML-193

AC   CVCL_1071

SY   AML193

DR   CLO; CLO_0001718

DR   CLDB; cl272

DR   ATCC; CRL-9589

DR   ATCC; HTB-188

DR   BCRJ; 0040

DR   BioSample; SAMN01821616

DR   BioSample; SAMN03471219

DR   CCLE; AML193_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 724816

DR   Cosmic; 787420

DR   Cosmic; 949089

DR   Cosmic; 975238

DR   Cosmic; 1012057

DR   Cosmic; 1281305

DR   Cosmic; 2306199

DR   DSMZ; ACC-549

DR   GEO; GSM886867

DR   GEO; GSM887932

RX   PubMed=2015403;

RX   PubMed=2656885;

RX   PubMed=3496132;

RX   PubMed=16408098;

RX   PubMed=22460905;

RX   PubMed=25984343;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=AML-193

WW   http://www.infarktforschung.de/macrophages_cell_lines.html

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Characteristics: CSF2 and IL3 dependent.

CC   Doubling time: 65 hours (PubMed=25984343); ~50-60 hours (DSMZ).

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: BCRJ; 0040; probable.

CC   Discontinued: ATCC; HTB-188; true.

ST   Source(s): ATCC; DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 12

ST   D5S818: 9,13

ST   D7S820: 9,12

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 15,17

DI   NCIt; C9160; Childhood acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AML12

AC   CVCL_0140

SY   AML-12; AML 12; Alpha Mouse Liver 12

DR   BTO; BTO:0003449

DR   CLO; CLO_0001716

DR   MCCL; MCC:0000033

DR   ATCC; CRL-2254

DR   BCRC; 60326

DR   BCRJ; 0354

DR   GEO; GSE87156

DR   GEO; GSM294842

DR   GEO; GSM296415

DR   GEO; GSM296416

DR   GEO; GSM296417

DR   GEO; GSM1374079

DR   GEO; GSM1374080

DR   GEO; GSM1374081

DR   GEO; GSM1374082

DR   GEO; GSM1374083

DR   GEO; GSM1374084

DR   IZSLER; BS CL 161

RX   PubMed=7904757;

CC   Characteristics: Produced in a transgenic mouse expressing human TGFA.

CC   Doubling time: 37 hours (PubMed=7904757).

CC   Omics: Transcriptome analysis.

CC   Breed/subspecies: CD-1 MT42 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   AML14 [Human leukemia]

AC   CVCL_8286

DR   Cosmic; 975237

DR   Cosmic; 1281304

RX   PubMed=8443379;

RX   PubMed=9474744;

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AML14 [Mouse liver]

AC   CVCL_K234

SY   AML-14; AML 14; Alpha Mouse Liver 14

RX   PubMed=7904757;

CC   Characteristics: Produced in a transgenic mouse expressing human TGFA.

CC   Doubling time: 32 hours (PubMed=7904757).

CC   Breed/subspecies: CD-1 MT42 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   AML14.3D10

AC   CVCL_0141

SY   AML14-3D10; AML143D10

DR   MCCL; MCC:0000034

DR   GEO; GSM1374391

RX   PubMed=9474744;

CC   Omics: Transcriptome analysis.

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8286 ! AML14 [Human leukemia]

SX   Male

CA   Cancer cell line

//

ID   AML14.3D10/CCCKR3 Clone 16

AC   CVCL_6337

DR   CLO; CLO_0001717

DR   ATCC; CRL-12079

DR   BioSample; SAMN03471345

CC   Transfected with: HGNC; 1604; CCR3.

CC   Discontinued: ATCC; CRL-12079; true.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 13

ST   D13S317: 12

ST   D16S539: 9,12

ST   D5S818: 10,11

ST   D7S820: 10,14

ST   TH01: 9,9.3

ST   TPOX: 9,11

ST   vWA: 18,19

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0141 ! AML14.3D10

SX   Male

CA   Cancer cell line

//

ID   AMN iPSC-3

AC   CVCL_B941

DR   ISCR; 1801

RX   PubMed=21721033;

CC   From: Yonsei University College of Medicine; Seoul; South Korea.

DI   NCIt; C61252; Adrenoleukodystrophy

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   AMO1

AC   CVCL_1806

SY   AMo1; AMO-1

DR   EFO; EFO_0006534

DR   BioSample; SAMN03473529

DR   BioSample; SAMN03472930

DR   CCLE; AMO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   CGH-DB; 9156-4

DR   Cosmic; 1483074

DR   Cosmic; 1889514

DR   Cosmic; 2131561

DR   Cosmic; 2391800

DR   Cosmic-CLP; 1295741

DR   DSMZ; ACC-538

DR   GDSC; 1295741

DR   GEO; GSM143353

DR   GEO; GSM290285

DR   GEO; GSM886868

DR   GEO; GSM887933

DR   GEO; GSM1374392

DR   GEO; GSM1669599

RX   PubMed=8426482;

RX   PubMed=9738977;

RX   PubMed=10936422;

RX   PubMed=11429052;

RX   PubMed=12886255;

RX   PubMed=15215163;

RX   PubMed=18700954;

RX   PubMed=17171682;

RX   PubMed=19306352;

RX   PubMed=21173094;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~70-90 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8

ST   D16S539: 9,13

ST   D18S51: 15,18

ST   D21S11: 30,33.2

ST   D3S1358: 15,18

ST   D5S818: 12

ST   D7S820: 9,11

ST   D8S1179: 13,15

ST   FGA: 19,24

ST   Penta D: 9,15

ST   Penta E: 11

ST   TH01: 7,9

ST   TPOX: 8,9 (Cosmic-CLP; DSMZ)

ST   TPOX: 8 (PubMed=25877200)

ST   vWA: 17,18

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AMOC-2

AC   CVCL_C830

SY   AMOC2

RX   PubMed=2794621;

RX   PubMed=9433040;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AMOC-2 Subclone #10

AC   CVCL_AT98

RX   PubMed=9433040;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_C830 ! AMOC-2

SX   Female

CA   Cancer cell line

//

ID   AMOC-2 Subclone #11

AC   CVCL_AT99

RX   PubMed=9433040;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_C830 ! AMOC-2

SX   Female

CA   Cancer cell line

//

ID   AMOC-2 Subclone #2

AC   CVCL_AT95

RX   PubMed=9433040;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_C830 ! AMOC-2

SX   Female

CA   Cancer cell line

//

ID   AMOC-2 Subclone #4

AC   CVCL_AT96

RX   PubMed=9433040;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_C830 ! AMOC-2

SX   Female

CA   Cancer cell line

//

ID   AMOC-2 Subclone #6

AC   CVCL_AT97

RX   PubMed=9433040;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_C830 ! AMOC-2

SX   Female

CA   Cancer cell line

//

ID   AMOS-III

AC   CVCL_0E45

SY   AII MS Oral Squamous cell carcinoma-III

RX   Patent=US6730514;

RX   PubMed=13679204;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Ampli-GPE

AC   CVCL_4104

DR   CLO; CLO_0001719

DR   CLDB; cl273

DR   ECACC; 95050229

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   AMR10

AC   CVCL_U845

RX   PubMed=7734848;

CC   Monoclonal antibody target: ChEBI; CHEBI:27499; Ganglioside GM4.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   AMR19

AC   CVCL_U831

DR   CLO; CLO_0050334

DR   RCB; RCB2016

RX   PubMed=8026889;

CC   Monoclonal antibody target: Ganglioside GD3-lactone (GD3-L).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   AMR20

AC   CVCL_U832

DR   CLO; CLO_0050341

DR   RCB; RCB2041

CC   Monoclonal antibody target: ChEBI; CHEBI:36498; Galactosylceramide (GalCer).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   AMR38

AC   CVCL_U833

RX   PubMed=8026889;

CC   Monoclonal antibody target: Ganglioside GM1-lactone (GM1-L).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   AMR40

AC   CVCL_U834

RX   PubMed=8026889;

CC   Monoclonal antibody target: Ganglioside GD1a-lactone (GD1a-L).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_J288 ! PAI

CA   Hybridoma

//

ID   AMS 9.1.1.1

AC   CVCL_K123

DR   CLO; CLO_0001720

DR   ATCC; HB-161

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   AMS3

AC   CVCL_H629

RX   PubMed=8183550;

RX   PubMed=15356658;

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Amsalem

AC   CVCL_B386

DR   ATCC; CRL-2628

RX   PubMed=2981779;

CC   Discontinued: ATCC; CRL-2628; true.

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AMU-AML1

AC   CVCL_M584

RX   PubMed=21965128;

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AMU-ML1

AC   CVCL_M583

RX   CelloPub=CLPUB00017;

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   An Bay

AC   CVCL_U667

DR   ATCC; CRL-1256

CC   Discontinued: ATCC; CRL-1256; true.

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   An Na

AC   CVCL_U766

DR   ATCC; CRL-1183

CC   Discontinued: ATCC; CRL-1183; true.

DI   NCIt; C125701; Ehlers-Danlos syndrome, type VII

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   An Zan

AC   CVCL_3644

DR   CLO; CLO_0001721

DR   ATCC; CRL-1266

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   AN3-CA

AC   CVCL_0028

SY   AN3 CA; AN3 Ca; AN3CA; AN-3; AN3

DR   BTO; BTO:0001771

DR   CLO; CLO_0001722

DR   EFO; EFO_0002110

DR   ATCC; HTB-111

DR   BCRJ; 0363

DR   BioSample; SAMN03471092

DR   BioSample; SAMN03473131

DR   BioSample; SAMN03473336

DR   CCLE; AN3CA_ENDOMETRIUM

DR   CCRID; 3142C0001000000098

DR   ChEMBL-Cells; CHEMBL3308708

DR   ChEMBL-Targets; CHEMBL1075392

DR   CLS; 300119/p494_AN3_Ca

DR   Cosmic; 687550

DR   Cosmic; 699283

DR   Cosmic; 713473

DR   Cosmic; 713495

DR   Cosmic; 809134

DR   Cosmic; 846176

DR   Cosmic; 871551

DR   Cosmic; 889116

DR   Cosmic; 910781

DR   Cosmic; 980634

DR   Cosmic; 1007162

DR   Cosmic; 1057760

DR   Cosmic; 1066221

DR   Cosmic; 1070810

DR   Cosmic; 1102376

DR   Cosmic; 1105620

DR   Cosmic; 1177683

DR   Cosmic; 1223484

DR   Cosmic; 1434192

DR   Cosmic; 1576450

DR   Cosmic; 1622894

DR   Cosmic; 1696752

DR   Cosmic; 2030460

DR   Cosmic-CLP; 910781

DR   DSMZ; ACC-267

DR   GDSC; 910781

DR   GEO; GSM374970

DR   GEO; GSM375429

DR   GEO; GSM827494

DR   GEO; GSM886869

DR   GEO; GSM887934

DR   GEO; GSM1669600

DR   IGRhCellID; AN3CA

DR   IZSLER; BS TCL 200

DR   TOKU-E; 543

RX   PubMed=327080;

RX   PubMed=14207855;

RX   PubMed=22460905;

RX   PubMed=22710073;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.proteinatlas.org/learn/cellines

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ERK genetic alteration cell panel (ATCC TCP-1033).

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).

CC   Doubling time: ~55 hours (DSMZ).

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep antibody staining analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12,14,15 (ATCC; CLS; Cosmic-CLP; PubMed=25877200)

ST   CSF1PO: 12,14 (DSMZ)

ST   D13S317: 12,14

ST   D16S539: 10,14 (ATCC; CLS; DSMZ; PubMed=25877200)

ST   D16S539: 10,14,15 (Cosmic-CLP)

ST   D18S51: 15,18

ST   D21S11: 29,30

ST   D3S1358: 17

ST   D5S818: 11,14

ST   D7S820: 7,7.1,10 (ATCC; PubMed=25877200)

ST   D7S820: 7,10 (CLS; Cosmic-CLP)

ST   D7S820: 7.1,10 (DSMZ)

ST   D8S1179: 12,14

ST   FGA: 23

ST   Penta D: 9,11

ST   Penta E: 9,16

ST   TH01: 9.3,10

ST   TPOX: 8,10

ST   vWA: 14,20

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AN4;11

AC   CVCL_AY52

SY   AN4-11

DR   Cosmic; 2393013

RX   PubMed=8353274;

RX   PubMed=8358709;

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ANA-1

AC   CVCL_0142

SY   Ana-1; ANA1

DR   BTO; BTO:0002775

DR   MCCL; MCC:0000035

DR   CCRID; 3131C0001000300002

DR   KCB; KCB 200784YJ

RX   PubMed=2778838;

WW   http://www.infarktforschung.de/macrophages_cell_lines.html

CC   Transformant: Recombinant retrovirus J2.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   Ana-104

AC   CVCL_Z534

SY   Ana 104; Ana104

RX   CelloPub=CLPUB00189;

RX   CelloPub=CLPUB00190;

RX   DOI=10.3969/j.issn.1673-5234.2000.04.020;

CC   Group: Insect cell line.

OX   NCBI_TaxID=74872; ! Anopheles anthropophagus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ANBL-6

AC   CVCL_5425

SY   ANBL6

DR   Cosmic; 720790

DR   Cosmic; 1170891

DR   Cosmic; 2081377

DR   Cosmic; 2367285

RX   PubMed=8221668;

RX   PubMed=8943038;

RX   PubMed=10583232;

RX   PubMed=10936422;

RX   PubMed=16956823;

RX   PubMed=21173094;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=ANBL-6

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M523 ! ANBM-6

SX   Female

CA   Cancer cell line

//

ID   ANBM-6

AC   CVCL_M523

SY   ANBM6

RX   PubMed=9022078;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_5425 ! ANBL-6

SX   Female

CA   Cancer cell line

//

ID   AND-1

AC   CVCL_B526

SY   AND1; ESe029-A

DR   BioSamples; SAMEA7772668

DR   hPSCreg; ESe029-A

DR   ISCR; 1635

RX   PubMed=19401322;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/AND-1.pdf

CC   From: Andalusian Stem Cell Bank; Granada; Spain.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   AND-1 FLT3 D835

AC   CVCL_V161

SY   AND1-FLT3 D835; AND-1 FLT3-TKD; AND1-FLT3 TKD

DR   ISCR; 2204

RX   PubMed=23479570;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Dossier-AND1-FLT3-D835.pdf

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B526 ! AND-1

SX   Male

CA   Embryonic stem cell

//

ID   AND-1 FLT3 ITD

AC   CVCL_V160

SY   AND-1 FLT3-ITD; AND1-FLT3 ITD

DR   ISCR; 2203

RX   PubMed=23479570;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Dossier_AND1-FLT3-ITD.pdf

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B526 ! AND-1

SX   Male

CA   Embryonic stem cell

//

ID   AND-1 MLLAF4

AC   CVCL_V162

SY   AND-1-MLLAF4; AND1-MLLAF4

DR   ISCR; 2205

RX   PubMed=23479570;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Dossier-AND1-MLLAF4.pdf

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B526 ! AND-1

SX   Male

CA   Embryonic stem cell

//

ID   AND-1 MLLAF4 FLT3 D835

AC   CVCL_V163

SY   AND1-MLLAF4 FLT3 D835; AND1-MLLAF4/FLT3-TKD

DR   ISCR; 2206

RX   PubMed=23479570;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Dossier-AND1-MLLAF4-FLT3-D835.pdf

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B526 ! AND-1

SX   Male

CA   Embryonic stem cell

//

ID   AND-1 MLLAF4 FLT3 ITD

AC   CVCL_V164

SY   AND1-MLLAF4 FLT3 ITD; AND1-MLLAF4/FLT3-ITD

DR   ISCR; 2207

RX   PubMed=23479570;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Dossier_AND1-MLLAF4-FLT3-ITD.pdf

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B526 ! AND-1

SX   Male

CA   Embryonic stem cell

//

ID   AND-1 WASKO C1.1

AC   CVCL_V158

DR   ISCR; 2201

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud-Deposito-Lineas-Celulares-AND-1-WASKO-C1-1.pdf

CC   Knockout cell: Method=ZFN; HGNC; 12731; WAS.

DI   NCIt; C3448; Wiskott-Aldrich syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B526 ! AND-1

SX   Male

CA   Embryonic stem cell

//

ID   AND-1 WASKO C1.2

AC   CVCL_V159

DR   ISCR; 2202

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/Solicitud-Deposito-Lineas-Celulares-AND-1-WASKO-C1-2.pdf

CC   Knockout cell: Method=ZFN; HGNC; 12731; WAS.

DI   NCIt; C3448; Wiskott-Aldrich syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B526 ! AND-1

SX   Male

CA   Embryonic stem cell

//

ID   AND-2

AC   CVCL_B527

SY   AND2

DR   ISCR; 1636

RX   PubMed=19401322;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/AND-2.pdf

CC   From: Andalusian Stem Cell Bank; Granada; Spain.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   AND-3

AC   CVCL_B528

SY   AND3

DR   ISCR; 1637

RX   PubMed=19401322;

WW   http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-ejecucion/fd-programas-investigacion/fd-investigacion-terapia-celular-medicina-regenerativa/fd-banco-nacional-lineas-celulares/fd-lineas-celulares-disponibles/AND-3.pdf

CC   From: Andalusian Stem Cell Bank; Granada; Spain.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   ANDP

AC   CVCL_F823

DR   IMGT/HLA; 10250

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ANE58

AC   CVCL_Z178

SY   ANE 58; ANE 64

DR   TCB; 3071

RX   PubMed=2766897;

RX   PubMed=6644089;

RX   PubMed=17662657;

RX   PubMed=22743047;

RX   PubMed=23140894;

WW   https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf

CC   Group: Tick cell line.

CC   Miscellaneous: Called ANE 64 in the original publication (PubMed=6644089), but seems to have been called ANE58/ANE 58 since in all other publications from the same authors.

OX   NCBI_TaxID=60253; ! Dermacentor nitens

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Anglne

AC   CVCL_U287

DR   CCRID; 3142C0001000000049

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ANGM-CSS

AC   CVCL_2297

DR   ECACC; 08040401

RX   PubMed=24366606;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Angu-BL

AC   CVCL_7173

SY   Angu

RX   PubMed=9882297;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Anip-973

AC   CVCL_6879

SY   Anip 973; ANIP 973; Anip[973]; Anip973; ANIP973

RX   PubMed=14989933;

RX   PubMed=20723345;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6878 ! AGZY83-a

CA   Cancer cell line

//

ID   Anip973/CDDP

AC   CVCL_W193

RX   PubMed=20723345;

RX   PubMed=20738915;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6879 ! Anip-973

CA   Cancer cell line

//

ID   Anip973/NVB

AC   CVCL_W194

SY   Anip973/Navelbine

RX   PubMed=17650408;

RX   PubMed=20738915;

RX   PubMed=22429577;

CC   Selected for resistance to: ChEBI; CHEBI:480999; Vinorelbine (Navelbine; NVB).

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_6879 ! Anip-973

CA   Cancer cell line

//

ID   Anjou 65

AC   CVCL_3645

SY   ANJOU 65; Anjou-65

DR   CLO; CLO_0001724

DR   ATCC; CRL-11269

DR   BioSample; SAMN03471333

DR   Wikidata; Q28197162

RX   Patent=WO1994019478A1;

RX   PubMed=7690960;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-90.html

CC   Group: Retrovirus packaging cell line.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12,14

ST   D16S539: 9,13

ST   D5S818: 8,9

ST   D7S820: 11

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 16,18,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1926 ! HEK293T/17

SX   Female

CA   Transformed cell line

//

ID   ANN-1

AC   CVCL_9242

DR   CLO; CLO_0001725

DR   ChEMBL-Cells; CHEMBL3307385

DR   ChEMBL-Targets; CHEMBL614520

RX   PubMed=163444;

CC   Transformant: NCBI_TaxID; 11788; Abelson mouse leukemia virus (AbMuLV).

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Transformed cell line

//

ID   ANO

AC   CVCL_F533

SY   TER282; TER357

DR   IMGT/HLA; 12178

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Anr13-1

AC   CVCL_4575

DR   CLO; CLO_0050620

DR   RCB; RCB0451

CC   Breed/subspecies: Fischer 344/DuCrj.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4107 ! ARLJ 301-3

SX   Male

CA   Transformed cell line

//

ID   Anr4

AC   CVCL_4105

DR   CLO; CLO_0001726

DR   CLO; CLO_0050621

DR   CLDB; cl277

DR   ChEMBL-Cells; CHEMBL3308415

DR   ChEMBL-Targets; CHEMBL614521

DR   ECACC; 90071808

DR   RCB; RCB0449

CC   Breed/subspecies: Fischer 344/DuCrj.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4107 ! ARLJ 301-3

SX   Male

CA   Transformed cell line

//

ID   Anr9-1

AC   CVCL_4576

DR   CLO; CLO_0050619

DR   RCB; RCB0450

CC   Breed/subspecies: Fischer 344/DuCrj.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4107 ! ARLJ 301-3

SX   Male

CA   Transformed cell line

//

ID   Anso-242

AC   CVCL_Z536

SY   Anso 242; Anso242

RX   CelloPub=CLPUB00190;

RX   DOI=10.3969/j.issn.1673-5234.2000.04.020;

CC   Group: Insect cell line.

OX   NCBI_TaxID=74873; ! Anopheles sinensis

SX   Female

CA   Spontaneously immortalized cell line

//

ID   anti-130-kDa Mesothelial-Ciliated Cells

AC   CVCL_L580

DR   CLO; CLO_0001729

DR   ATCC; CRL-2401

RX   PubMed=7603040;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   Anti-alpha(1)1C6F4

AC   CVCL_U847

SY   1C6F4

DR   CLO; CLO_0050312

DR   RCB; RCB1240

RX   PubMed=2544482;

CC   Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-alpha(10)10E3B7

AC   CVCL_U848

SY   10E3B7

RX   PubMed=2544482;

CC   Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-alpha(2)E2B5

AC   CVCL_U849

SY   E2B5

RX   PubMed=2544482;

CC   Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-alpha(3)7E7C2

AC   CVCL_U850

SY   7E7C2

RX   PubMed=2544482;

CC   Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-alpha(4)11D9G5

AC   CVCL_U851

SY   11D9G5

DR   CLO; CLO_0050346

DR   RCB; RCB1243

RX   PubMed=2544482;

CC   Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-alpha(5)11D10B6

AC   CVCL_U852

SY   11D10B6

DR   CLO; CLO_0050347

DR   RCB; RCB1244

RX   PubMed=2544482;

CC   Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-alpha(6)11D10F7

AC   CVCL_U853

SY   11D10F7

RX   PubMed=2544482;

CC   Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-alpha(7)7C9A10

AC   CVCL_U854

SY   7C9A10

DR   CLO; CLO_0050344

DR   RCB; RCB1246

RX   PubMed=2544482;

CC   Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-alpha(8)9F3A6

AC   CVCL_U855

SY   9F3A6

DR   CLO; CLO_0050313

DR   RCB; RCB1247

RX   PubMed=2544482;

CC   Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-alpha(9)12G8B11

AC   CVCL_U856

SY   12G8B11

DR   CLO; CLO_0050348

DR   RCB; RCB1248

RX   PubMed=2544482;

CC   Monoclonal antibody target: UniProtKB; P0C216; C.perfringens plc.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   anti-alphaA-crystallin

AC   CVCL_U830

DR   CLO; CLO_0050315

DR   RCB; RCB1303

RX   PubMed=7832826;

CC   Monoclonal antibody target: UniProtKB; P02504; Chicken CRYAA.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   anti-alphaB-crystallin

AC   CVCL_U813

DR   CLO; CLO_0050304

DR   RCB; RCB1304

RX   PubMed=7832826;

CC   Monoclonal antibody target: UniProtKB; Q05713; Chicken CRYAB.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   anti-beta5-crystallin

AC   CVCL_U826

DR   CLO; CLO_0050305

DR   RCB; RCB1305

RX   PubMed=7832826;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   anti-beta6-crystallin

AC   CVCL_U827

DR   CLO; CLO_0050306

DR   RCB; RCB1306

RX   PubMed=7832826;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   anti-delta-crystallin

AC   CVCL_U829

DR   CLO; CLO_0050322

DR   RCB; RCB1308

RX   PubMed=7832826;

CC   Monoclonal antibody target: UniProtKB; P02521; Chicken DLS1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   Anti-FHA(1)1C6

AC   CVCL_U639

SY   1C6

DR   CLO; CLO_0050394

DR   RCB; RCB1239

CC   Monoclonal antibody target: UniProtKB; P12255; Bordetella pertussis filamentous hemagglutinin (fhaB).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-FHA(2)2E9

AC   CVCL_U640

SY   2E9

DR   CLO; CLO_0050393

DR   RCB; RCB1238

CC   Monoclonal antibody target: UniProtKB; P12255; Bordetella pertussis filamentous hemagglutinin (fhaB).

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   anti-gamma1-crystallin

AC   CVCL_U828

DR   CLO; CLO_0050307

DR   RCB; RCB1307

RX   PubMed=7832826;

CC   Monoclonal antibody target: UniProtKB; Q8QFU3; Cynops pyrrhogaster gamma-crystallin.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   Anti-My-10 clone 28/8/8/14/4

AC   CVCL_L094

DR   CLO; CLO_0001731

DR   ATCC; HB-8483

DR   KCLB; 88483

RX   Patent=US4714680;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-PT-S1-10D6

AC   CVCL_U641

SY   10D6

DR   CLO; CLO_0050358

DR   RCB; RCB1208

RX   PubMed=1698179;

RX   PubMed=1894382;

CC   Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-PT-S1-1B7

AC   CVCL_U642

SY   1B7

DR   CLO; CLO_0050345

DR   RCB; RCB1205

RX   PubMed=1698179;

RX   PubMed=1894382;

RX   PubMed=6094351;

CC   Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-PT-S1-3F10

AC   CVCL_U643

SY   3F10

DR   CLO; CLO_0050402

DR   RCB; RCB1212

RX   PubMed=1698179;

RX   PubMed=1894382;

RX   PubMed=6094351;

CC   Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-PT-S1-4D10

AC   CVCL_U644

SY   4D10

DR   CLO; CLO_0050399

DR   RCB; RCB1214

RX   PubMed=1698179;

RX   PubMed=1894382;

CC   Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-PT-S1-8G4

AC   CVCL_U645

SY   8G4

DR   CLO; CLO_0050359

DR   RCB; RCB1209

RX   PubMed=1698179;

RX   PubMed=1894382;

CC   Monoclonal antibody target: UniProtKB; P04977; Bordetella pertussis ptxA.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-PT-S2-3A12

AC   CVCL_U646

SY   3A12

DR   CLO; CLO_0050309

DR   RCB; RCB1220

RX   PubMed=1894382;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-PT-S2-9G8

AC   CVCL_U647

SY   9G8

DR   CLO; CLO_0050401

DR   RCB; RCB1222

RX   PubMed=1698179;

RX   PubMed=1894382;

CC   Monoclonal antibody target: UniProtKB; P04978; Bordetella pertussis ptxB.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-PT-S23-11E6

AC   CVCL_U648

SY   11E6

DR   CLO; CLO_0050308

DR   RCB; RCB1215

RX   PubMed=1698179;

RX   PubMed=1894382;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-PT-S3-7E10

AC   CVCL_U649

SY   7E10

DR   CLO; CLO_0050310

DR   RCB; RCB1223

RX   PubMed=1698179;

RX   PubMed=1894382;

CC   Monoclonal antibody target: UniProtKB; P04979; Bordetella pertussis ptxC.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-PT-S4-1H2

AC   CVCL_U861

SY   1H2

DR   CLO; CLO_0050400

DR   RCB; RCB1233

RX   PubMed=1894382;

CC   Monoclonal antibody target: UniProtKB; P0A3R5; Bordetella pertussis ptxD.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-PT-S4-7F2

AC   CVCL_U650

SY   7F2

DR   CLO; CLO_0050311

DR   RCB; RCB1229

RX   PubMed=1894382;

CC   Monoclonal antibody target: UniProtKB; P0A3R5; Bordetella pertussis ptxD.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Anti-SC35

AC   CVCL_L674

DR   CLO; CLO_0001732

DR   ATCC; CRL-2031

DR   BCRC; 60171

RX   PubMed=2137203;

CC   Monoclonal antibody target: UniProtKB; Q01130; Human SRSF2/SC35.

CC   Misspelling: 'Anti-SSC35' in BCRC 60171.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6971 ! FOX-NY

CA   Hybridoma

//

ID   anti-SR

AC   CVCL_G689

SY   1H4

DR   CLO; CLO_0001733

DR   ATCC; CRL-2383

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6971 ! FOX-NY

CA   Hybridoma

//

ID   anti-SRp20

AC   CVCL_G690

SY   7B4

DR   CLO; CLO_0001734

DR   ATCC; CRL-2384

CC   Monoclonal antibody target: UniProtKB; P84103; Human SRSF3.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6971 ! FOX-NY

CA   Hybridoma

//

ID   Anti-theta(1)3H10

AC   CVCL_U857

SY   3H10

DR   CLO; CLO_0050314

DR   RCB; RCB1250

CC   Monoclonal antibody target: UniProtKB; P0C2E9; C.perfringens pfo.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   Antibody 2.06

AC   CVCL_L673

DR   CLO; CLO_0001730

DR   ATCC; HB-104

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   AO

AC   CVCL_D631

DR   BioSample; SAMN03151664

RX   PubMed=1246601;

RX   PubMed=4128382;

RX   PubMed=4472134;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=4472134, PubMed=20143388).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   Ao/I

AC   CVCL_AV09

RX   PubMed=26820856;

CC   Group: Insect cell line.

OX   NCBI_TaxID=480707; ! Adoxophyes orana

SX   Female

CA   Spontaneously immortalized cell line

//

ID   AO2V4

AC   CVCL_Z597

RX   PubMed=8943096;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8567 ! SK-AO2

SX   Male

CA   Cancer cell line

//

ID   AOK-B50

AC   CVCL_8171

DR   BTO; BTO:0003851

RX   PubMed=8386606;

CC   Breed/subspecies: Hampshire.

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_0391 ! LLC-PK1

SX   Male

CA   Spontaneously immortalized cell line

//

ID   AOTO

AC   CVCL_F643

RX   PubMed=15767549;

CC   Part of: JFCR45 cancer cell line panel.

CC   From: Kawaguchi T.; Department of Pathology; Cancer Institute, Japanese Foundation for Cancer Research; Tokyo; Japan.

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   AP

AC   CVCL_E457

DR   dbMHC; 48475

DR   IHW; IHW9229

DR   IMGT/HLA; 10251

WW   http://bioinformatics.hsanmartino.it/ecbr/cl229.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   AP-1

AC   CVCL_HF85

RX   PubMed=25137137;

CC   Doubling time: 3.342 days (PubMed=25137137).

DI   NCIt; C40409; Salivary gland pleomorphic adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AP-1 LUCPorter

AC   CVCL_W339

SY   AP-1 LUCPorter stable reporter cell line

CC   Transfected with: UniProtKB; P27652; Renilla-type luciferase.

CC   Transformant: NCBI_TaxID; 28285; Adenovirus 5.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0045 ! HEK293

SX   Female

CA   Transformed cell line

//

ID   AP-1060

AC   CVCL_1807

DR   BioSample; SAMN03473492

DR   DSMZ; ACC-593

RX   PubMed=15116119;

CC   Doubling time: ~80-100 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,12

ST   D16S539: 10,11

ST   D5S818: 12

ST   D7S820: 10,11

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C3182; Acute promyelocytic leukemia with t(15;17)(q22;q12) PML-RARA

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AP-16

AC   CVCL_5432

DR   IFO; IFO50424

RX   PubMed=8391585;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=AP-16

CC   Breed/subspecies: C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   AP-18

AC   CVCL_X041

RX   PubMed=16210832;

RX   PubMed=19947910;

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Spontaneously immortalized cell line

//

ID   AP-217

AC   CVCL_A052

DR   Cosmic; 1012058

RX   PubMed=9279364;

RX   PubMed=16408098;

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AP-3

AC   CVCL_J157

DR   CLO; CLO_0001736

DR   ATCC; HB-242

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   AP-64

AC   CVCL_Z826

RX   PubMed=9768180;

CC   Group: Insect cell line.

OX   NCBI_TaxID=316597; ! Aedes pseudoscutellaris

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   AP.6

AC   CVCL_G634

DR   CLO; CLO_0001735

DR   ATCC; CRL-2227

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   AP106

AC   CVCL_F534

DR   IMGT/HLA; 10252

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AP109

AC   CVCL_F535

DR   IMGT/HLA; 10253

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AP110

AC   CVCL_F536

DR   IMGT/HLA; 10254

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AP115

AC   CVCL_F537

DR   IMGT/HLA; 10255

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AP2

AC   CVCL_W419

RX   PubMed=9230912;

DI   NCIt; C4650; Parotid gland pleomorphic adenoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AP630

AC   CVCL_F538

SY   TER199; TER292

DR   IMGT/HLA; 10256

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AP7P

AC   CVCL_J287

DR   BioSample; SAMN03472407

DR   JCRB; JCRB3011

DR   JCRB; KURB1401

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 8,9

ST   D16S539: 10,11

ST   D5S818: 10

ST   D7S820: 10,12

ST   TH01: 9,10

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C125702; Fanconi anemia, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   AP7P(SVT)

AC   CVCL_L454

DR   JCRB; KURB1402

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C125702; Fanconi anemia, complementation group A

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_J287 ! AP7P

SX   Female

CA   Transformed cell line

//

ID   APA

AC   CVCL_E458

SY   TER61; TER224; TER258; TER452

DR   dbMHC; 48476

DR   ECACC; 94022522

DR   IHW; IHW9237

DR   IMGT/HLA; 10257

WW   http://bioinformatics.hsanmartino.it/ecbr/cl237.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   APD

AC   CVCL_E459

SY   GM06817

DR   CLO; CLO_0036534

DR   Coriell; GM06817

DR   dbMHC; 48477

DR   ECACC; 94071427

DR   IHW; IHW9291

DR   IMGT/HLA; 10258

RX   PubMed=6417008;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl291.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   APE1

AC   CVCL_Z272

RX   PubMed=8907121;

CC   Group: Insect cell line.

OX   NCBI_TaxID=247271; ! Antitrogus parvulus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   APHL1

AC   CVCL_Z273

RX   PubMed=8907121;

CC   Group: Insect cell line.

OX   NCBI_TaxID=247271; ! Antitrogus parvulus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   AQ

AC   CVCL_M613

DR   Cosmic; 848245

RX   PubMed=10632461;

DI   NCIt; C2946; Chondrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Ar Bo

AC   CVCL_U767

DR   ATCC; CRL-1272

CC   Discontinued: ATCC; CRL-1272; true.

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Ar Ke-2

AC   CVCL_3646

DR   CLO; CLO_0001739

DR   ATCC; CRL-1324

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Ar Lip

AC   CVCL_Y115

DR   ATCC; CRL-1233

CC   Discontinued: ATCC; CRL-1233; true.

DI   NCIt; C3040; Fibrodysplasia ossificans progressiva

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Ar Mor

AC   CVCL_U768

DR   ATCC; CRL-1221

RX   PubMed=3860870;

CC   Discontinued: ATCC; CRL-1221; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Ar-13

AC   CVCL_0I23

RX   PubMed=25761724;

CC   Group: Insect cell line.

CC   Doubling time: 3 days (PubMed=25761724).

OX   NCBI_TaxID=124917; ! Armigeres subalbatus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   Ar-3

AC   CVCL_0I24

RX   PubMed=25761724;

CC   Group: Insect cell line.

CC   Doubling time: 2.7 days (PubMed=25761724).

OX   NCBI_TaxID=124917; ! Armigeres subalbatus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   AR-5

AC   CVCL_F824

RX   PubMed=9886832;

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   AR-C40

AC   CVCL_8172

CC   Breed/subspecies: Hampshire.

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_0391 ! LLC-PK1

SX   Male

CA   Spontaneously immortalized cell line

//

ID   AR-EcoScreen

AC   CVCL_8544

DR   JCRB; JCRB1328

RX   PubMed=15110108;

RX   PubMed=15713541;

CC   Transfected with: HGNC; 644; AR.

CC   Transfected with: UniProtKB; P27652; Renilla-type luciferase.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   AR230

AC   CVCL_9478

SY   AR-230

DR   Cosmic; 787490

DR   Cosmic; 1026575

DR   Cosmic; 2364007

RX   PubMed=7606740;

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AR230-r

AC   CVCL_DP56

RX   PubMed=10910924;

CC   Selected for resistance to: ChEBI; CHEBI:45783; Imatinib (Gleevec; STI571).

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9478 ! AR230

SX   Female

CA   Cancer cell line

//

ID   AR230-rn

AC   CVCL_DP53

RX   PubMed=19047160;

CC   Selected for resistance to: ChEBI; CHEBI:52172; Nilotinib (AMN107; Tasigna).

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_9478 ! AR230

SX   Female

CA   Cancer cell line

//

ID   AR42J

AC   CVCL_0143

SY   AR4-2J; AR-42J

DR   BTO; BTO:0001928

DR   CLO; CLO_0001740

DR   MCCL; MCC:0000036

DR   CLDB; cl280

DR   CLDB; cl281

DR   ATCC; CRL-1492

DR   BCRC; 60160

DR   CCRID; 3131C0001001000006

DR   CCRID; 3142C0001000000134

DR   ChEMBL-Cells; CHEMBL3307902

DR   ChEMBL-Targets; CHEMBL614271

DR   CLS; 500478/p744_AR42J

DR   ECACC; 93100618

DR   TOKU-E; 555

RX   CelloPub=CLPUB00018;

RX   PubMed=7517639;

RX   PubMed=17392489;

WW   http://www.addexbio.com/productdetail?pid=24

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-364.html

CC   Breed/subspecies: Wistar.

DI   NCIt; C60682; Rat digestive system neoplasms

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   AR42J-B13

AC   CVCL_0E02

SY   AR42J-B-13; B-13

RX   PubMed=8756573;

RX   PubMed=20685382;

CC   Breed/subspecies: Wistar.

DI   NCIt; C60682; Rat digestive system neoplasms

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0143 ! AR42J

CA   Cancer cell line

//

ID   ARA

AC   CVCL_F548

SY   TER157; TER219; TER281

DR   IMGT/HLA; 10260

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ARA-10

AC   CVCL_A053

SY   Ara-10; ARA 10; ARA10

DR   Cosmic; 801734

RX   PubMed=6582512;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ARA016

AC   CVCL_F539

SY   TER324

DR   IMGT/HLA; 10261

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ARAC-8C

AC   CVCL_GZ09

SY   CCRF-CEM-AraC-8C; CEM/ARAC-8C; AraC-8C; Ara-C/8C

DR   TOKU-E; 4127

RX   PubMed=2842332;

RX   PubMed=18279955;

WW   http://icoregon.technologypublisher.com/technology/18057

CC   Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0207 ! CCRF-CEM

SX   Female

CA   Cancer cell line

//

ID   ARAC-8D

AC   CVCL_GZ10

SY   CCRF-CEM-AraC-8D; CEM-AraC-8D; AraC-8D; Ara-C/8D

RX   PubMed=2842332;

RX   PubMed=18279955;

WW   http://icoregon.technologypublisher.com/technology/18059

CC   Selected for resistance to: ChEBI; CHEBI:28680; Cytarabine (Arabinosylcytosine; Ara-C).

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0207 ! CCRF-CEM

SX   Female

CA   Cancer cell line

//

ID   ARAC25

AC   CVCL_F540

DR   IMGT/HLA; 10262

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Aramis

AC   CVCL_M600

SY   ARAMIS

RX   PubMed=12193296;

RX   PubMed=15320967;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ARBO

AC   CVCL_E460

DR   dbMHC; 48478

DR   IHW; IHW9102

DR   IMGT/HLA; 11614

WW   http://bioinformatics.hsanmartino.it/ecbr/cl102.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   ARBO C11

AC   CVCL_8832

RX   PubMed=638021;

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_8833 ! ARBO C9

CA   Finite cell line

//

ID   ARBO C9

AC   CVCL_8833

RX   PubMed=638021;

RX   PubMed=7190976;

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_8832 ! ARBO C11

CA   Finite cell line

//

ID   ARCaP

AC   CVCL_4830

SY   MDA PCa 1

DR   TOKU-E; 4101

RX   PubMed=8986779;

RX   PubMed=12725112;

RX   PubMed=14518029;

WW   http://capcelllines.ca/details.asp?id=85

CC   Derived from metastatic site: Ascites.

DI   NCIt; C4863; Prostate carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AREc32

AC   CVCL_1D32

DR   Ximbio; 151014

RX   PubMed=17108137;

WW   http://www.cxrbiosciences.com/technologies/arec32-cell-line/

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0031 ! MCF-7

SX   Female

CA   Cancer cell line

//

ID   ARH-77

AC   CVCL_1072

SY   ARH 77; ARH77

DR   BTO; BTO:0002992

DR   CLO; CLO_0001744

DR   CLO; CLO_0001745

DR   EFO; EFO_0002111

DR   CLDB; cl285

DR   ATCC; CRL-1621

DR   BCRC; 60385

DR   BioSample; SAMN03471407

DR   ChEMBL-Cells; CHEMBL3308536

DR   ChEMBL-Targets; CHEMBL2366241

DR   Cosmic; 759914

DR   Cosmic; 886086

DR   Cosmic; 888020

DR   Cosmic; 906765

DR   Cosmic; 919148

DR   Cosmic; 999792

DR   Cosmic-CLP; 906765

DR   DSMZ; ACC-512

DR   ECACC; 88121201

DR   GDSC; 906765

DR   GEO; GSM1374393

DR   GEO; GSM1669601

DR   IGRhCellID; ARH77

DR   Lonza; 593

RX   PubMed=566614;

RX   PubMed=7579375;

RX   PubMed=10516762;

RX   PubMed=10936422;

RX   PubMed=27397505;

CC   Problematic cell line: Misidentified. Originally thought to be a myeloma cell line but is a B-lymphoblastoid cell line (PubMed=7579375, PubMed=10516762).

CC   Doubling time: 110.4 hours (PubMed=566614); ~30 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: Occasionally 'AHR 77'.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC

ST   Amelogenin: X

ST   CSF1PO: 6,10

ST   D13S317: 11,13

ST   D16S539: 9,13

ST   D5S818: 10,13

ST   D7S820: 7,12

ST   TH01: 8,9.3

ST   TPOX: 8

ST   vWA: 17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   ARH-DR

AC   CVCL_W396

RX   CelloPub=CLPUB00019;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ARIP

AC   CVCL_3488

AS   CVCL_7243

SY   AR41P; AR4IP

DR   CLO; CLO_0001741

DR   CLO; CLO_0001746

DR   CLDB; cl282

DR   ATCC; CRL-1674

DR   ChEMBL-Cells; CHEMBL3308355

DR   ChEMBL-Targets; CHEMBL613534

DR   TOKU-E; 557

RX   CelloPub=CLPUB00018;

CC   Breed/subspecies: Wistar.

DI   NCIt; C60682; Rat digestive system neoplasms

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   ARIP/PDX-1

AC   CVCL_S556

RX   PubMed=11249068;

CC   Transfected with: RGD; 62387; Pdx1.

CC   Breed/subspecies: Wistar.

DI   NCIt; C60682; Rat digestive system neoplasms

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3488 ! ARIP

CA   Cancer cell line

//

ID   ARK

AC   CVCL_A760

SY   Ark; ark; ARK-B

DR   BTO; BTO:0003930

DR   Cosmic; 720774

DR   Cosmic; 760398

DR   Cosmic; 2302413

DR   Cosmic; 2367270

RX   PubMed=8427968;

RX   PubMed=8943038;

RX   PubMed=10936422;

RX   PubMed=11167840;

RX   PubMed=15381930;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ARL-14

AC   CVCL_4Z19

SY   ARL 14; Adult Rat Liver-14

RX   PubMed=427743;

RX   PubMed=2903442;

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Finite cell line

//

ID   ARL-15

AC   CVCL_0D75

SY   ARL 15; Adult Rat Liver-15

RX   PubMed=40692;

RX   PubMed=427743;

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Finite cell line

//

ID   ARL-15C1

AC   CVCL_0D77

DR   BTO; BTO:0005448

RX   PubMed=2870063;

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0D75 ! ARL-15

SX   Male

CA   Finite cell line

//

ID   ARL-16

AC   CVCL_0D76

SY   ARL 16; Adult Rat Liver-16

RX   PubMed=40692;

RX   PubMed=427743;

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Finite cell line

//

ID   ARL-16T2

AC   CVCL_0D78

DR   BTO; BTO:0005449

RX   PubMed=2870063;

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0D76 ! ARL-16

SX   Male

CA   Transformed cell line

//

ID   ARL-18

AC   CVCL_4Z20

SY   ARL 18; Adult Rat Liver-18

RX   PubMed=427743;

RX   PubMed=2903442;

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Finite cell line

//

ID   ARL-19

AC   CVCL_4Z21

SY   ARL 19; Adult Rat Liver-19

RX   PubMed=2903442;

CC   Breed/subspecies: Fischer 344.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Finite cell line

//

ID   ARL-6

AC   CVCL_4106

SY   ARL 6; Adult Rat Liver-6

DR   CLO; CLO_0001747

DR   CLDB; cl286

DR   ECACC; 87050701

RX   PubMed=40692;

RX   PubMed=427743;

RX   PubMed=2903442;

RX   PubMed=4373256;

CC   Breed/subspecies: Wistar.

DI   NCIt; C60416; Rat hepatocellular carcinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   ARLJ 301-3

AC   CVCL_4107

SY   ARLJ301-3

DR   CLO; CLO_0050623

DR   CLO; CLO_0001748

DR   CLDB; cl287

DR   ECACC; 90071806

DR   JCRB; JCRB0248

DR   RCB; RCB0447

RX   CelloPub=CLPUB00160;

CC   Breed/subspecies: Fischer 344/DuCrj.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   ARLJ 301-3TR1

AC   CVCL_5243

SY   ARLJ301-3TR1

DR   CLO; CLO_0050622

DR   RCB; RCB0448

CC   Breed/subspecies: Fischer 344/DuCrj.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4107 ! ARLJ 301-3

SX   Male

CA   Transformed cell line

//

ID   ARM-C

AC   CVCL_IW83

RX   PubMed=23372829;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IW84 ! ARM-E

OI   CVCL_IW85 ! ARM-G

OI   CVCL_IW86 ! ARM-H

OI   CVCL_IW87 ! ARM-X

SX   Female

CA   Cancer cell line

//

ID   ARM-E

AC   CVCL_IW84

RX   PubMed=23372829;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IW83 ! ARM-C

OI   CVCL_IW85 ! ARM-G

OI   CVCL_IW86 ! ARM-H

OI   CVCL_IW87 ! ARM-X

SX   Female

CA   Cancer cell line

//

ID   ARM-G

AC   CVCL_IW85

RX   PubMed=23372829;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IW83 ! ARM-C

OI   CVCL_IW84 ! ARM-E

OI   CVCL_IW86 ! ARM-H

OI   CVCL_IW87 ! ARM-X

SX   Female

CA   Cancer cell line

//

ID   ARM-H

AC   CVCL_IW86

RX   PubMed=23372829;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IW83 ! ARM-C

OI   CVCL_IW84 ! ARM-E

OI   CVCL_IW85 ! ARM-G

OI   CVCL_IW87 ! ARM-X

SX   Female

CA   Cancer cell line

//

ID   ARM-X

AC   CVCL_IW87

RX   PubMed=23372829;

DI   NCIt; C4194; Invasive ductal carcinoma, not otherwise specified

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_IW83 ! ARM-C

OI   CVCL_IW84 ! ARM-E

OI   CVCL_IW85 ! ARM-G

OI   CVCL_IW86 ! ARM-H

SX   Female

CA   Cancer cell line

//

ID   ARM193

AC   CVCL_B992

DR   CLO; CLO_0050317

DR   RCB; RCB0002

CC   Monoclonal antibody target: UniProtKB; P0A7G6; Escherichia coli recA.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   ARM321

AC   CVCL_B993

DR   CLO; CLO_0050290

DR   RCB; RCB0115

CC   Monoclonal antibody target: UniProtKB; P0A7G6; Escherichia coli recA.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   ARMD1-hiPSC1

AC   CVCL_B960

SY   ARMD.1.H.iPSC.1

DR   RSCB; RSCB0120

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B962 ! ARMD1-hiPSC2

OI   CVCL_B963 ! ARMD1-hiPSC4

OI   CVCL_B964 ! ARMD1-hiPSC5

OI   CVCL_B965 ! ARMD1-hiPSC8

OI   CVCL_B966 ! ARMD1-hiPSC9

OI   CVCL_B961 ! ARMD1-hiPSC11

SX   Female

CA   Induced pluripotent stem cell

//

ID   ARMD1-hiPSC11

AC   CVCL_B961

SY   ARMD.1.H.iPSC.11

DR   RSCB; RSCB0126

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B960 ! ARMD1-hiPSC1

OI   CVCL_B962 ! ARMD1-hiPSC2

OI   CVCL_B963 ! ARMD1-hiPSC4

OI   CVCL_B964 ! ARMD1-hiPSC5

OI   CVCL_B965 ! ARMD1-hiPSC8

OI   CVCL_B966 ! ARMD1-hiPSC9

SX   Female

CA   Induced pluripotent stem cell

//

ID   ARMD1-hiPSC2

AC   CVCL_B962

SY   ARMD.1.H.iPSC.2; RIi013-A

DR   hPSCreg; RIi013-A

DR   RSCB; RSCB0121

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B960 ! ARMD1-hiPSC1

OI   CVCL_B963 ! ARMD1-hiPSC4

OI   CVCL_B964 ! ARMD1-hiPSC5

OI   CVCL_B965 ! ARMD1-hiPSC8

OI   CVCL_B966 ! ARMD1-hiPSC9

OI   CVCL_B961 ! ARMD1-hiPSC11

SX   Female

CA   Induced pluripotent stem cell

//

ID   ARMD1-hiPSC4

AC   CVCL_B963

SY   ARMD.1.H.iPSC.4

DR   RSCB; RSCB0122

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B960 ! ARMD1-hiPSC1

OI   CVCL_B962 ! ARMD1-hiPSC2

OI   CVCL_B964 ! ARMD1-hiPSC5

OI   CVCL_B965 ! ARMD1-hiPSC8

OI   CVCL_B966 ! ARMD1-hiPSC9

OI   CVCL_B961 ! ARMD1-hiPSC11

SX   Female

CA   Induced pluripotent stem cell

//

ID   ARMD1-hiPSC5

AC   CVCL_B964

SY   ARMD.1.H.iPSC.5

DR   RSCB; RSCB0123

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B960 ! ARMD1-hiPSC1

OI   CVCL_B962 ! ARMD1-hiPSC2

OI   CVCL_B963 ! ARMD1-hiPSC4

OI   CVCL_B965 ! ARMD1-hiPSC8

OI   CVCL_B966 ! ARMD1-hiPSC9

OI   CVCL_B961 ! ARMD1-hiPSC11

SX   Female

CA   Induced pluripotent stem cell

//

ID   ARMD1-hiPSC8

AC   CVCL_B965

SY   ARMD.1.H.iPSC.8

DR   RSCB; RSCB0124

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B960 ! ARMD1-hiPSC1

OI   CVCL_B962 ! ARMD1-hiPSC2

OI   CVCL_B963 ! ARMD1-hiPSC4

OI   CVCL_B964 ! ARMD1-hiPSC5

OI   CVCL_B966 ! ARMD1-hiPSC9

OI   CVCL_B961 ! ARMD1-hiPSC11

SX   Female

CA   Induced pluripotent stem cell

//

ID   ARMD1-hiPSC9

AC   CVCL_B966

SY   ARMD.1.H.iPSC.9

DR   RSCB; RSCB0125

CC   From: Royan Institute; Theran; Iran.

DI   NCIt; C84391; Macular degeneration

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_B960 ! ARMD1-hiPSC1

OI   CVCL_B962 ! ARMD1-hiPSC2

OI   CVCL_B963 ! ARMD1-hiPSC4

OI   CVCL_B964 ! ARMD1-hiPSC5

OI   CVCL_B965 ! ARMD1-hiPSC8

OI   CVCL_B961 ! ARMD1-hiPSC11

SX   Female

CA   Induced pluripotent stem cell

//

ID   ARNT

AC   CVCL_E461

SY   ARENT; GM03153

DR   CLO; CLO_0013523

DR   Coriell; GM03153

DR   dbMHC; 48479

DR   ECACC; 94071428

DR   IHW; IHW9292

DR   IMGT/HLA; 10264

WW   http://bioinformatics.hsanmartino.it/ecbr/cl292.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   ARO

AC   CVCL_0144

SY   ARO 81-1; ARO81-1; ARO-81; ARO81; UCLA-RO 81; UCLA RO-81-A-1; UCLA RO-81A-1

DR   BTO; BTO:0002306

DR   MCCL; MCC:0000037

DR   BioSample; SAMN03151786

DR   BioSample; SAMN03151787

DR   CGH-DB; 55-1

DR   ChEMBL-Cells; CHEMBL3307996

DR   ChEMBL-Targets; CHEMBL612590

DR   Cosmic; 685603

DR   Cosmic; 755291

DR   Cosmic; 849972

DR   Cosmic; 886550

DR   Cosmic; 888094

DR   Cosmic; 888277

DR   Cosmic; 891254

DR   Cosmic; 913250

DR   Cosmic; 918184

DR   Cosmic; 931242

DR   Cosmic; 990532

DR   Cosmic; 1005458

DR   Cosmic; 1094760

DR   Cosmic; 1152116

DR   Cosmic; 1155329

DR   Cosmic; 1162836

DR   Cosmic; 1184761

DR   Cosmic; 1699417

DR   Cosmic; 2050371

DR   TOKU-E; 4069

RX   PubMed=16924234;

RX   PubMed=18713817;

RX   PubMed=20143388;

RX   PubMed=21868764;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HT-29 derivative (PubMed=18713817, PubMed=20143388, PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.

CC   From: Juillard G.J.F.; University of California, Los Angeles; Los Angeles; USA.

ST   Source(s): PubMed=18713817; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 11,12

ST   D18S51: 12,13

ST   D21S11: 30

ST   D3S1358: 15,17

ST   D5S818: 11,12

ST   D7S820: 10

ST   D8S1179: 10,16

ST   FGA: 20,22

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 17,19

DI   NCIt; C43584; Rectosigmoid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0320 ! HT-29

SX   Female

CA   Cancer cell line

//

ID   ARP-1

AC   CVCL_D523

SY   ARP1; AR-P1

DR   BTO; BTO:0003931

DR   Cosmic; 2367264

RX   PubMed=7949178;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ARPE-19

AC   CVCL_0145

SY   ARPE19; Adult Retinal Pigment Epithelial cell line-19; NTC-200; NTC200

DR   BTO; BTO:0002335

DR   CLO; CLO_0001749

DR   EFO; EFO_0006271

DR   MCCL; MCC:0000038

DR   ATCC; CRL-2302

DR   BCRC; 60383

DR   BCRJ; 0041

DR   BioSample; SAMN03471862

DR   IZSLER; BS CL 193

DR   Lonza; 871

DR   Wikidata; Q28812659

RX   PubMed=8698076;

RX   PubMed=11504951;

RX   PubMed=16262907;

RX   PubMed=21697133;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-617.html

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 9,11

ST   D5S818: 13

ST   D7S820: 9,11

ST   TH01: 6,9.3

ST   TPOX: 9,11

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Spontaneously immortalized cell line

//

ID   ARPE-19/CNTF

AC   CVCL_IQ60

SY   ARPE/CNTF; ARPE-P444; NTC-201; NTC201

RX   Patent=US6361771;

CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2524.

CC   Transfected with: HGNC; 2169; CNTF.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0145 ! ARPE-19

SX   Male

CA   Spontaneously immortalized cell line

//

ID   ARPE-19/CNTF-10

AC   CVCL_IQ63

SY   NTC-201-10

RX   CelloPub=CLPUB00369;

CC   Transfected with: HGNC; 2169; CNTF.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_IQ60 ! ARPE-19/CNTF

SX   Male

CA   Spontaneously immortalized cell line

//

ID   ARPE-19/CNTF-6A

AC   CVCL_IQ64

SY   NTC-201-6A

RX   CelloPub=CLPUB00369;

CC   Transfected with: HGNC; 2169; CNTF.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_IQ60 ! ARPE-19/CNTF

SX   Male

CA   Spontaneously immortalized cell line

//

ID   ARPE-19/EGFP

AC   CVCL_IQ61

SY   ARPE/GFP; P-393-1; NTC200p393(1)

RX   Patent=US6361771;

CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2522.

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0145 ! ARPE-19

SX   Male

CA   Spontaneously immortalized cell line

//

ID   ARPE-19/GDNF

AC   CVCL_IQ62

SY   ARPE/GDNF; ARPE-19/p559; NTC200p559

RX   Patent=US6361771;

CC   Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2523.

CC   Transfected with: HGNC; 4232; GDNF.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0145 ! ARPE-19

SX   Male

CA   Spontaneously immortalized cell line

//

ID   ARPE-19/HPV-16

AC   CVCL_6338

DR   CLO; CLO_0001750

DR   ATCC; CRL-2502

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D16S539: 9,11

ST   D5S818: 13

ST   D7S820: 9,11

ST   TH01: 6,9.3

ST   TPOX: 9,11

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0145 ! ARPE-19

SX   Male

CA   Transformed cell line

//

ID   AS [Human neuroblastoma]

AC   CVCL_S099

RX   PubMed=7073944;

CC   Doubling time: 35.8 hours (PubMed=7073944).

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AS [Salmon]

AC   CVCL_6F68

RX   DOI=10.1139/f73-152;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8030; ! Salmo salar

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   AS iPS del 1-0

AC   CVCL_U498

SY   ASdel1-0; AG1-0

RX   PubMed=20876107;

WW   https://www.kerafast.com/product/1545/angelman-syndrome-ag1-0-human-induced-pluripotent-stem-cells

DI   NCIt; C75462; Angelman syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_U499 ! AS iPS del 1-1

SX   Female

CA   Induced pluripotent stem cell

//

ID   AS iPS del 1-1

AC   CVCL_U499

SY   ASdel1-1

RX   PubMed=20876107;

DI   NCIt; C75462; Angelman syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_U498 ! AS iPS del 1-0

SX   Female

CA   Induced pluripotent stem cell

//

ID   AS iPS del 2-0

AC   CVCL_U500

SY   ASdel2-0

RX   PubMed=20876107;

DI   NCIt; C75462; Angelman syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5I46 ! WG1631

SX   Male

CA   Induced pluripotent stem cell

//

ID   AS iPS del 2-3

AC   CVCL_U501

SY   ASdel2-3

RX   PubMed=20876107;

DI   NCIt; C75462; Angelman syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5I46 ! WG1631

SX   Male

CA   Induced pluripotent stem cell

//

ID   AS 33

AC   CVCL_J975

DR   CLO; CLO_0001751

DR   ATCC; HB-8779

RX   Patent=US5160723;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   AS-1

AC   CVCL_DC71

DR   ATCC; CRL-8118

RX   Patent=US5024946;

RX   PubMed=2470715;

CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: ATCC; CRL-8118; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2710 ! RPMI-1788

SX   Male

CA   Transformed cell line

//

ID   AS-D-653-TC

AC   CVCL_F988

SY   AS-D-653

DR   TKG; TKG 0117

DR   TKG; TKG 0671

CC   Breed/subspecies: Donryu.

DI   NCIt; C60505; Rat sarcoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   AS-E2

AC   CVCL_6769

DR   Cosmic; 787421

DR   Cosmic; 975239

DR   Cosmic; 1012059

DR   Cosmic; 1281306

DR   Cosmic; 2306200

RX   PubMed=9369430;

RX   PubMed=16408098;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=AS-E2

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AS-H 1

AC   CVCL_Z499

RX   DOI=10.1080/03235409009438961;

CC   Group: Insect cell line.

OX   NCBI_TaxID=47767; ! Agrotis segetum

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   AS-H 4

AC   CVCL_Z500

RX   DOI=10.1080/03235409009438961;

CC   Group: Insect cell line.

OX   NCBI_TaxID=47767; ! Agrotis segetum

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   AS-M

AC   CVCL_8656

RX   PubMed=14741847;

DI   NCIt; C4489; Skin angiosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AS-M.5

AC   CVCL_8657

RX   PubMed=14741847;

DI   NCIt; C4489; Skin angiosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8656 ! AS-M

SX   Male

CA   Cancer cell line

//

ID   AS034

AC   CVCL_B340

SY   AS 034; CEBe002-A

DR   hPSCreg; CEBe002-A

DR   ISCR; 59

RX   PubMed=15153613;

RX   PubMed=20177996;

CC   From: Cellectis/Cellartis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   AS034.1

AC   CVCL_B341

SY   CEBe003-A

DR   hPSCreg; CEBe003-A

DR   ISCR; 57

RX   PubMed=15153613;

RX   PubMed=20177996;

CC   From: Cellectis/Cellartis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B340 ! AS034

SX   Male

CA   Embryonic stem cell

//

ID   AS034.1.1

AC   CVCL_B342

SY   CEBe005-A

DR   hPSCreg; CEBe005-A

DR   ISCR; 56

RX   PubMed=20177996;

CC   From: Cellectis/Cellartis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B341 ! AS034.1

SX   Male

CA   Embryonic stem cell

//

ID   AS034.2

AC   CVCL_B343

SY   CEBe004-A

DR   hPSCreg; CEBe004-A

DR   ISCR; 58

CC   From: Cellectis/Cellartis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B340 ! AS034

SX   Male

CA   Embryonic stem cell

//

ID   AS038

AC   CVCL_B344

SY   AS 038; CEBe006-A

DR   hPSCreg; CEBe006-A

DR   ISCR; 60

RX   PubMed=15153613;

RX   PubMed=20177996;

CC   From: Cellectis/Cellartis.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   AS079

AC   CVCL_B345

SY   CEBe008-A

DR   hPSCreg; CEBe008-A

DR   ISCR; 61

CC   From: Cellectis/Cellartis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   AS094

AC   CVCL_B346

DR   ISCR; 207

CC   From: Cellectis/Cellartis.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   AS17

AC   CVCL_8536

DR   JCRB; JCRB1392

RX   PubMed=9084877;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   AS283A

AC   CVCL_A761

SY   As283A

DR   Cosmic; 1515198

RX   PubMed=1325212;

RX   PubMed=2052620;

RX   PubMed=8344493;

RX   PubMed=8515068;

RX   PubMed=9973220;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   As4.1

AC   CVCL_0151

SY   As41; Clone 4.1

DR   CLO; CLO_0001753

DR   MCCL; MCC:0000043

DR   ATCC; CRL-2193

RX   PubMed=2174057;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   ASAN-PaCa

AC   CVCL_GP71

DR   Cosmic; 2566118

RX   PubMed=27518460;

CC   Doubling time: 20 hours (PubMed=27518460).

CC   Omics: Deep exome analysis.

DI   NCIt; C38342; Pancreatic intraductal papillary-mucinous neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Asano

AC   CVCL_D299

DR   Cosmic; 945372

RX   PubMed=8980248;

DI   NCIt; C7550; Ovarian serous adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ASB-10W

AC   CVCL_8626

RX   PubMed=4052977;

CC   Transformant: ChEBI; CHEBI:46661; Asbestos.

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

SX   Female

CA   Transformed cell line

//

ID   ASB-410

AC   CVCL_8648

RX   PubMed=4052977;

CC   Transformant: ChEBI; CHEBI:46661; Asbestos.

OX   NCBI_TaxID=10036; ! Mesocricetus auratus

SX   Male

CA   Transformed cell line

//

ID   ASB-XIII

AC   CVCL_5685

SY   ASB XIII

RX   PubMed=6652624;

CC   Transformant: ChEBI; CHEBI:46661; Asbestos.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   ASB-XIV

AC   CVCL_5686

SY   ASB XIV

DR   CLS; 400120/p585_ASB-XIV

RX   PubMed=6652624;

CC   Transformant: ChEBI; CHEBI:46661; Asbestos.

CC   Breed/subspecies: BALB/c.

DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   ASBB

AC   CVCL_A017

SY   Asian Sea Bass Brain

RX   PubMed=21082288;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8187; ! Lates calcarifer

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ASC-17D

AC   CVCL_6D60

SY   Adult Sertoli Cell-17 clone D

RX   PubMed=8562702;

RX   PubMed=15716129;

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Conditionally immortalized cell line

//

ID   ASC52telo

AC   CVCL_U602

AS   CVCL_9Q54

SY   ASC/TERT1

DR   ATCC; SCRC-4000

DR   BioSample; SAMN03471937

RX   PubMed=19125642;

WW   http://www.evercyte.com/asc-tert1-91.html

CC   Transfected with: HGNC; 11730; TERT.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 8,12

ST   D16S539: 10,13

ST   D5S818: 11,13

ST   D7S820: 8,11

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Telomerase immortalized cell line

//

ID   ASC57telo

AC   CVCL_U603

DR   ATCC; SCRC-4001

DR   BioSample; SAMN03471938

RX   PubMed=19125642;

CC   Doubling time: ~40 hours (ATCC).

CC   Transfected with: HGNC; 11730; TERT.

CC   Discontinued: ATCC; SCRC-4001; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 8,10

ST   D13S317: 9,12

ST   D16S539: 11,12

ST   D5S818: 10,11

ST   D7S820: 8

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 15,16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Telomerase immortalized cell line

//

ID   ASE

AC   CVCL_6G15

SY   Atlantic Salmon Embryo

RX   CelloPub=CLPUB00103;

RX   DOI=10.3147/jsfp.28.27;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8030; ! Salmo salar

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ASF-1

AC   CVCL_S925

CC   Group: Fish cell line.

OX   NCBI_TaxID=34773; ! Alosa sapidissima

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ASF-4-1

AC   CVCL_2854

DR   BioSample; SAMN03472790

DR   IFO; IFO50418

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,13

ST   D13S317: 11,12

ST   D16S539: 10,11

ST   D5S818: 9,10

ST   D7S820: 10,11

ST   TH01: 8,9

ST   TPOX: 11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2855 ! ASF-4-2

OI   CVCL_8497 ! ASF-4-3L

OI   CVCL_8498 ! ASF-4-4L1

OI   CVCL_8499 ! ASF-4-4L2

OI   CVCL_8500 ! ASF-4-4R2

SX   Male

CA   Finite cell line

//

ID   ASF-4-2

AC   CVCL_2855

DR   IFO; IFO50419

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,13

ST   D13S317: 11,12

ST   D16S539: 10,11

ST   D5S818: 9,10

ST   D7S820: 10,11

ST   TH01: 8,9

ST   TPOX: 11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2854 ! ASF-4-1

OI   CVCL_8497 ! ASF-4-3L

OI   CVCL_8498 ! ASF-4-4L1

OI   CVCL_8499 ! ASF-4-4L2

OI   CVCL_8500 ! ASF-4-4R2

SX   Male

CA   Finite cell line

//

ID   ASF-4-3L

AC   CVCL_8497

DR   JCRB; JCRB1431

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,13

ST   D13S317: 11,12

ST   D16S539: 10,11

ST   D5S818: 9,10

ST   D7S820: 10,11

ST   TH01: 8,9

ST   TPOX: 11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2854 ! ASF-4-1

OI   CVCL_2855 ! ASF-4-2

OI   CVCL_8498 ! ASF-4-4L1

OI   CVCL_8499 ! ASF-4-4L2

OI   CVCL_8500 ! ASF-4-4R2

SX   Male

CA   Finite cell line

//

ID   ASF-4-4L1

AC   CVCL_8498

DR   JCRB; JCRB1441

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,13

ST   D13S317: 11,12

ST   D16S539: 10,11

ST   D5S818: 9,10

ST   D7S820: 10,11

ST   TH01: 8,9

ST   TPOX: 11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2854 ! ASF-4-1

OI   CVCL_2855 ! ASF-4-2

OI   CVCL_8497 ! ASF-4-3L

OI   CVCL_8499 ! ASF-4-4L2

OI   CVCL_8500 ! ASF-4-4R2

SX   Male

CA   Finite cell line

//

ID   ASF-4-4L2

AC   CVCL_8499

DR   JCRB; JCRB1442

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,13

ST   D13S317: 11,12

ST   D16S539: 10,11

ST   D5S818: 9,10

ST   D7S820: 10,11

ST   TH01: 8,9

ST   TPOX: 11

ST   vWA: 17,18

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2854 ! ASF-4-1

OI   CVCL_2855 ! ASF-4-2

OI   CVCL_8497 ! ASF-4-3L

OI   CVCL_8498 ! ASF-4-4L1

OI   CVCL_8500 ! ASF-4-4R2

SX   Male

CA   Finite cell line

//

ID   ASF-4-4R2

AC   CVCL_8500

DR   JCRB; JCRB1446

CC   Discontinued: JCRB; JCRB1446; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2854 ! ASF-4-1

OI   CVCL_2855 ! ASF-4-2

OI   CVCL_8497 ! ASF-4-3L

OI   CVCL_8498 ! ASF-4-4L1

OI   CVCL_8499 ! ASF-4-4L2

SX   Male

CA   Finite cell line

//

ID   ASH

AC   CVCL_R966

SY   Atlantic Salmon Heart

RX   PubMed=6767657;

CC   Group: Fish cell line.

CC   From: Gillespie J.H.; Cornell University College of Veterinary Medicine; Ithaca; USA.

OX   NCBI_TaxID=8030; ! Salmo salar

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ASH-3

AC   CVCL_2856

DR   BioSample; SAMN03470933

DR   Cosmic; 2054110

DR   Cosmic-CLP; 1290722

DR   GDSC; 1290722

DR   GEO; GSM827189

DR   GEO; GSM1669602

DR   JCRB; JCRB1073

DR   JCRB; NIHS0269

RX   PubMed=11686581;

RX   PubMed=23833040;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Discontinued: JCRB; NIHS0269; true.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,14

ST   D13S317: 12

ST   D16S539: 9

ST   D18S51: 13,17

ST   D19S433: 13,15.2

ST   D21S11: 28

ST   D2S1338: 19,23

ST   D3S1358: 15

ST   D5S818: 11,13

ST   D7S820: 11

ST   D8S1179: 16

ST   FGA: 20,22

ST   Penta D: 10,11

ST   Penta E: 5

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ASHS2

AC   CVCL_C549

DR   CCRID; 3153C0001000000149

OX   NCBI_TaxID=30527; ! Ovis ammon

SX   Sex undetermined

CA   Undefined cell line type

//

ID   ASHS3

AC   CVCL_C550

DR   CCRID; 3153C0001000000150

OX   NCBI_TaxID=30527; ! Ovis ammon

SX   Sex undetermined

CA   Undefined cell line type

//

ID   ASimf20

AC   CVCL_AZ82

SY   Atlantic Salmon intestinal myofibroblast 20

RX   CelloPub=CLPUB00326;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8030; ! Salmo salar

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ASK

AC   CVCL_4108

SY   Atlantic Salmon Kidney

DR   CLO; CLO_0001755

DR   ATCC; CRL-2747

DR   CCLV; CCLV-RIE 0926

DR   GEO; GSM281567

DR   GEO; GSM281568

DR   GEO; GSM281569

DR   GEO; GSM281570

DR   GEO; GSM281571

DR   GEO; GSM281572

RX   PubMed=10785858;

RX   PubMed=15825496;

RX   PubMed=18534703;

RX   PubMed=19941903;

CC   Group: Fish cell line.

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=8030; ! Salmo salar

SX   Female

CA   Spontaneously immortalized cell line

//

ID   Aska-SS

AC   CVCL_6C43

DR   RCB; RCB3576

RX   PubMed=20518020;

DI   NCIt; C3400; Synovial sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ASO

AC   CVCL_R967

SY   Atlantic Salmon Ovary

RX   PubMed=6767657;

CC   Group: Fish cell line.

CC   From: Gillespie J.H.; Cornell University College of Veterinary Medicine; Ithaca; USA.

OX   NCBI_TaxID=8030; ! Salmo salar

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ASP309

AC   CVCL_AZ83

SY   Atlantic Salmon Pituitary 309

RX   CelloPub=CLPUB00327;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8030; ! Salmo salar

SX   Female

CA   Spontaneously immortalized cell line

//

ID   ASP409

AC   CVCL_AZ84

SY   Atlantic Salmon Pituitary 409

RX   CelloPub=CLPUB00327;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8030; ! Salmo salar

SX   Female

CA   Spontaneously immortalized cell line

//

ID   AsPC-1

AC   CVCL_0152

SY   AsPc-1; Aspc-1; ASPC-1; As-PC1; ASPC1; AsPC1; Aspc1; AsPc1

DR   BTO; BTO:0001864

DR   CLO; CLO_0001756

DR   EFO; EFO_0002112

DR   MCCL; MCC:0000044

DR   CLDB; cl289

DR   ATCC; CRL-1682

DR   BCRC; 60494

DR   BioSample; SAMN03471961

DR   CCLE; ASPC1_PANCREAS

DR   CCRID; 3111C0001CCC000214

DR   CCRID; 3131C0001000700008

DR   CGH-DB; 160-1

DR   CGH-DB; 9271-4

DR   ChEMBL-Cells; CHEMBL3307994

DR   ChEMBL-Targets; CHEMBL612588

DR   CLS; 300158/p611_AsPC-1

DR   Cosmic; 707247

DR   Cosmic; 710851

DR   Cosmic; 724645

DR   Cosmic; 808166

DR   Cosmic; 868239

DR   Cosmic; 872994

DR   Cosmic; 910702

DR   Cosmic; 913308

DR   Cosmic; 918050

DR   Cosmic; 922255

DR   Cosmic; 923164

DR   Cosmic; 932514

DR   Cosmic; 933515

DR   Cosmic; 947398

DR   Cosmic; 948371

DR   Cosmic; 948740

DR   Cosmic; 949230

DR   Cosmic; 1006364

DR   Cosmic; 1090374

DR   Cosmic; 1108341

DR   Cosmic; 1198210

DR   Cosmic; 1320465

DR   Cosmic; 1366285

DR   Cosmic; 1477433

DR   Cosmic; 1571783

DR   Cosmic; 1644318

DR   Cosmic; 1995341

DR   Cosmic; 2434085

DR   Cosmic-CLP; 910702

DR   ECACC; 96020930

DR   GDSC; 910702

DR   GEO; GSM206446

DR   GEO; GSM495808

DR   GEO; GSM621911

DR   GEO; GSM784702

DR   GEO; GSM886870

DR   GEO; GSM887935

DR   GEO; GSM1024396

DR   GEO; GSM1374394

DR   GEO; GSM1374395

DR   GEO; GSM1374396

DR   GEO; GSM1588607

DR   GEO; GSM1669603

DR   IGRhCellID; AsPC1

DR   IZSLER; BS TCL 171

DR   KCLB; 21682

DR   NCBI_Iran; C558

DR   PRIDE; PXD003198

DR   SKY/M-FISH/CGH; 1997

RX   DOI=10.4172/jpb.1000057;

RX   PubMed=4023565;

RX   PubMed=6582512;

RX   PubMed=9185703;

RX   PubMed=9665481;

RX   PubMed=10027410;

RX   PubMed=11169959;

RX   PubMed=11787853;

RX   PubMed=12692724;

RX   PubMed=14695172;

RX   PubMed=15126341;

RX   PubMed=15688027;

RX   PubMed=18380791;

RX   PubMed=20418756;

RX   PubMed=22460905;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27259358;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/AsPC1.html

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=AsPC-1

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=66

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 46 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Proteome analysis by 2D-DE/MS.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,13 (ATCC; CLS; Cosmic-CLP; KCLB; PubMed=25877200)

ST   CSF1PO: 11,13 (ECACC)

ST   D13S317: 9,12 (ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=25877200)

ST   D13S317: 12 (CLS)

ST   D16S539: 11

ST   D18S51: 18

ST   D21S11: 28,30

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 12,13

ST   D8S1179: 13,15

ST   FGA: 24

ST   Penta D: 9,12

ST   Penta E: 5,12

ST   TH01: 7,9.3

ST   TPOX: 8,10

ST   vWA: 17

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AsPC-1/CMV-Luc

AC   CVCL_J243

DR   JCRB; JCRB1454

DR   JCRB; NIHS0697

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; NIHS0697; true.

CC   Derived from metastatic site: Ascites.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 9,12

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 12,13

ST   TH01: 7,9.3

ST   TPOX: 8,10

ST   vWA: 17

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0152 ! AsPC-1

SX   Female

CA   Cancer cell line

//

ID   ASPS-1

AC   CVCL_S738

DR   GEO; GSM1676317

DR   GEO; GSM1701624

RX   PubMed=21552147;

RX   PubMed=26351324;

DI   NCIt; C3750; Alveolar soft part sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ASPS-KY

AC   CVCL_S737

DR   Cosmic; 1333043

RX   CelloPub=CLPUB00020;

RX   PubMed=19380023;

DI   NCIt; C3750; Alveolar soft part sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Asra-EPS

AC   CVCL_W949

RX   PubMed=23915498;

CC   Doubling time: 38 hours (PubMed=23915498).

DI   NCIt; C3714; Epithelioid sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AST

AC   CVCL_S100

RX   PubMed=7073944;

CC   Doubling time: 40.7 hours (PubMed=7073944).

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AST-1

AC   CVCL_0G16

RX   PubMed=1319986;

RX   PubMed=9738977;

DI   NCIt; C3466; T-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Astro 1

AC   CVCL_6A98

RX   PubMed=8365576;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   Astro 2

AC   CVCL_6A99

RX   PubMed=8365576;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   Astro 3

AC   CVCL_6B00

RX   PubMed=8365576;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   Astro 4

AC   CVCL_6B01

RX   PubMed=8365576;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   Astro.4U

AC   CVCL_AQ52

WW   http://axiogenesis.com/products/neuronal-cells/astro-4u-hipsc-astrocytes.html

CC   From: Axiogenesis AG; Germany.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Induced pluripotent stem cell

//

ID   ASTC-a-1

AC   CVCL_C867

SY   ASTCa1

DR   BTO; BTO:0005015

CC   From: Department of Medicine; Jinan University; China.

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ASZ001

AC   CVCL_6251

DR   Lonza; 778

RX   PubMed=16881970;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   AT

AC   CVCL_E462

DR   dbMHC; 48480

DR   ECACC; 94022523

DR   IHW; IHW9221

DR   IMGT/HLA; 10268

WW   http://bioinformatics.hsanmartino.it/ecbr/cl221.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AT(L)5KY

AC   CVCL_2857

DR   JCRB; JCRB0331

DR   JCRB; KURB1795

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1G64 ! AT5KY

SX   Male

CA   Transformed cell line

//

ID   AT(L)6KY

AC   CVCL_2858

DR   BioSample; SAMN03471622

DR   JCRB; JCRB0332

DR   JCRB; KURB1800

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 11

ST   D5S818: 9,11

ST   D7S820: 10,11

ST   TH01: 7,9

ST   TPOX: 8,9

ST   vWA: 14,18

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1G66 ! AT6KY

SX   Male

CA   Transformed cell line

//

ID   AT(L)7KY

AC   CVCL_2859

DR   BioSample; SAMN03471624

DR   JCRB; JCRB0333

DR   JCRB; KURB1806

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 9,13

ST   D13S317: 8,12

ST   D16S539: 10,11

ST   D5S818: 9,12

ST   D7S820: 11,13

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1G68 ! AT7KY

SX   Male

CA   Transformed cell line

//

ID   AT-1

AC   CVCL_6271

DR   Lonza; 739

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Undefined cell line type

//

ID   AT-2

AC   CVCL_DI26

RX   PubMed=12127395;

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_A300 ! UoC-B12

SX   Male

CA   Cancer cell line

//

ID   AT-MS-1

AC   CVCL_W198

RX   PubMed=3761063;

DI   NCIt; C6064; Maxillary sinus squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   AT-PDH1TKB

AC   CVCL_L558

DR   CLO; CLO_0050715

DR   BioSample; SAMN03472287

DR   RCB; RCB0546

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,12

ST   D16S539: 9,12

ST   D5S818: 11,12

ST   D7S820: 8,12

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C103968; Pyruvate dehydrogenase deficiency

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   AT13ABR

AC   CVCL_IW68

RX   PubMed=9150358;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT1ABR

AC   CVCL_M911

RX   PubMed=2836804;

RX   PubMed=7792600;

RX   PubMed=9150358;

RX   PubMed=9168117;

RX   PubMed=11080496;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT1BE

AC   CVCL_X707

DR   ATCC; CRL-1312

RX   PubMed=865488;

CC   Discontinued: ATCC; CRL-1312; probable.

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   AT1OS

AC   CVCL_2860

DR   BioSample; SAMN03471616

DR   JCRB; JCRB0308

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 9

ST   D16S539: 9,12

ST   D5S818: 10

ST   D7S820: 11,12

ST   TH01: 9

ST   TPOX: 10,11

ST   vWA: 17,18

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   AT22IJE-T

AC   CVCL_D566

RX   PubMed=2539904;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AT24

AC   CVCL_M974

SY   A-T24

RX   PubMed=12080467;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT27RMO

AC   CVCL_IW73

RX   PubMed=9150358;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT2ABR

AC   CVCL_IW69

RX   PubMed=2825700;

RX   PubMed=9150358;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT2BE

AC   CVCL_V560

SY   Se Pan

DR   ATCC; CRL-1343

RX   PubMed=865488;

RX   PubMed=2973075;

RX   PubMed=6810166;

RX   PubMed=7471105;

CC   Discontinued: ATCC; CRL-1343; probable.

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   AT2KY

AC   CVCL_2861

DR   BioSample; SAMN03471619

DR   JCRB; JCRB0316

DR   JCRB; KURB1777

DR   JCRB; KURB1778

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 12

ST   D5S818: 9,10

ST   D7S820: 11

ST   TH01: 7,9

ST   TPOX: 9,12

ST   vWA: 18

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   AT2KY TERT

AC   CVCL_L457

DR   JCRB; KURB1779

CC   Transfected with: HGNC; 11730; TERT.

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2861 ! AT2KY

SX   Female

CA   Telomerase immortalized cell line

//

ID   AT2SF

AC   CVCL_V575

RX   PubMed=2903889;

RX   PubMed=2987007;

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   AT3ABR

AC   CVCL_M912

RX   PubMed=2825700;

RX   PubMed=2836804;

RX   PubMed=9150358;

RX   PubMed=9168117;

RX   PubMed=11080496;

CC   Characteristics: Heterozygous for the ATM p.Lys2756Ter mutation.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT3B-1

AC   CVCL_3489

SY   AT3B1

DR   CLO; CLO_0001760

DR   ATCC; CRL-2375

DR   ChEMBL-Cells; CHEMBL3308085

DR   ChEMBL-Targets; CHEMBL613873

RX   PubMed=9494564;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Breed/subspecies: Copenhagen.

DI   NCIt; C64013; Adenocarcinoma of the rat prostate

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0146 ! R-3327-AT-3

SX   Male

CA   Cancer cell line

//

ID   AT3B-2

AC   CVCL_Y657

RX   PubMed=9494564;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Breed/subspecies: Copenhagen.

DI   NCIt; C64013; Adenocarcinoma of the rat prostate

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_0146 ! R-3327-AT-3

SX   Male

CA   Cancer cell line

//

ID   AT3BE

AC   CVCL_X705

SY   NeNo

DR   ATCC; CRL-1347

CC   Discontinued: ATCC; CRL-1347; probable.

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   AT3BI

AC   CVCL_V545

DR   JCRB; KURB1821

RX   PubMed=2987007;

RX   PubMed=7471105;

RX   PubMed=7471106;

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   AT3KY

AC   CVCL_1G69

DR   JCRB; KURB1786

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   AT4BI

AC   CVCL_V546

DR   JCRB; KURB1761

RX   PubMed=865488;

RX   PubMed=2973075;

RX   PubMed=6810166;

RX   PubMed=7471106;

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   AT4BI(SV)

AC   CVCL_4Y28

DR   JCRB; KURB1762

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_V546 ! AT4BI

SX   Male

CA   Transformed cell line

//

ID   AT45LA

AC   CVCL_N319

RX   PubMed=9150358;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT4ABR

AC   CVCL_N288

RX   PubMed=2836804;

RX   PubMed=9150358;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT4JTO

AC   CVCL_M812

DR   JCRB; KURB1810

RX   PubMed=7057793;

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   AT4KY

AC   CVCL_1G70

DR   JCRB; KURB1787

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   AT4KY TERT

AC   CVCL_1G71

DR   JCRB; KURB1788

CC   Transfected with: HGNC; 11730; TERT.

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1G70 ! AT4KY

SX   Male

CA   Telomerase immortalized cell line

//

ID   AT59

AC   CVCL_M972

SY   AT-59; AT 59; A-T59

RX   PubMed=12080467;

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT5ABR

AC   CVCL_M913

RX   PubMed=9150358;

RX   PubMed=9168117;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT5BI

AC   CVCL_7441

SY   AT 5BI; GM05823; GM05823C; GM5823; GM5823A

DR   CLO; CLO_0024679

DR   Coriell; GM05823

DR   JCRB; KURB1822

RX   PubMed=2903889;

RX   PubMed=2973075;

RX   PubMed=6600729;

RX   PubMed=6810166;

RX   PubMed=6843573;

RX   PubMed=7471105;

RX   PubMed=7471106;

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   AT5BIVA

AC   CVCL_7442

SY   AT5BiSv40; AT5BISV40; GM05849; GM5849; GM05849B

DR   CLO; CLO_0024705

DR   Coriell; GM05849

DR   Lonza; 258

DR   TOKU-E; 4105

RX   PubMed=2821020;

RX   PubMed=3023120;

RX   PubMed=11172010;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7441 ! AT5BI

SX   Male

CA   Transformed cell line

//

ID   AT5KY

AC   CVCL_1G64

DR   JCRB; KURB1791

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   AT5KY TERT

AC   CVCL_1G65

DR   JCRB; KURB1793

CC   Transfected with: HGNC; 11730; TERT.

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1G64 ! AT5KY

SX   Male

CA   Telomerase immortalized cell line

//

ID   AT76LA

AC   CVCL_N320

RX   PubMed=9150358;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT79LA

AC   CVCL_IW74

RX   PubMed=9150358;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT6ABR

AC   CVCL_IW70

RX   PubMed=9150358;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT6KY

AC   CVCL_1G66

DR   JCRB; KURB1796

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   AT6KY TERT

AC   CVCL_1G67

DR   JCRB; KURB1797

CC   Transfected with: HGNC; 11730; TERT.

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1G66 ! AT6KY

SX   Male

CA   Telomerase immortalized cell line

//

ID   AT7BI

AC   CVCL_1G63

RX   PubMed=2903889;

RX   PubMed=7471106;

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   AT7KY

AC   CVCL_1G68

DR   JCRB; KURB1804

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   AT805

AC   CVCL_8068

DR   CLO; CLO_0050533

DR   RCB; RCB1788

CC   Breed/subspecies: 129.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   AT8ABR

AC   CVCL_IW71

RX   PubMed=2825700;

RX   PubMed=2836804;

RX   PubMed=9150358;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AT9ABR

AC   CVCL_IW72

RX   PubMed=9150358;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   ATC-10

AC   CVCL_Z222

SY   ATC 10; ATC10; Singh's Aedes aegyptic cell line; ATP-10

DR   CLO; CLO_0001670

DR   CLDB; cl248

DR   ATCC; CCL-125

DR   ECACC; 87091801

RX   CelloPub=CLPUB00178;

RX   DOI=10.2307/3576172;

RX   PubMed=5142320;

RX   PubMed=6137452;

RX   PubMed=6468178;

RX   PubMed=16037617;

RX   PubMed=16593348;

WW   http://garfield.library.upenn.edu/classics1984/A1984SB92200002.pdf

WW   https://www.vectorbase.org/data/aedes-aegypti-ccl-125-cell-line-avcl

CC   Group: Insect cell line.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=7159; ! Aedes aegypti

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-121

AC   CVCL_Z224

RX   CelloPub=CLPUB00179;

RX   PubMed=6468178;

RX   PubMed=16037617;

CC   Group: Insect cell line.

OX   NCBI_TaxID=317808; ! Aedes vittatus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-136

AC   CVCL_Z225

RX   PubMed=5544717;

RX   PubMed=6468178;

RX   PubMed=16037617;

CC   Group: Insect cell line.

OX   NCBI_TaxID=69821; ! Aedes w-albus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-137

AC   CVCL_Z226

RX   PubMed=5544717;

RX   PubMed=16037617;

CC   Group: Insect cell line.

OX   NCBI_TaxID=69821; ! Aedes w-albus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-15

AC   CVCL_Z223

SY   ATC 15; ATC15; Singh's Aedes albopictus cell line; Aa

DR   CLO; CLO_0001627

DR   CLO; CLO_0001671

DR   CLDB; cl226

DR   CLDB; cl249

DR   CLDB; cl250

DR   ATCC; CCL-126

DR   ECACC; 90100401

DR   IZSLER; BS CL 1

RX   CelloPub=CLPUB00178;

RX   PubMed=5142320;

RX   PubMed=8799737;

RX   PubMed=6468178;

RX   PubMed=16037617;

WW   http://garfield.library.upenn.edu/classics1984/A1984SB92200002.pdf

WW   http://www.rccc.cytspb.rssi.ru/ecellbank/spinless/saa.htm

CC   Group: Insect cell line.

OX   NCBI_TaxID=7160; ! Aedes albopictus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-173

AC   CVCL_Z227

RX   PubMed=4691922;

RX   PubMed=6468178;

RX   PubMed=16037617;

CC   Group: Insect cell line.

OX   NCBI_TaxID=1579489; ! Aedes novalbopictus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-176

AC   CVCL_Z228

RX   PubMed=4691922;

CC   Group: Insect cell line.

OX   NCBI_TaxID=1579489; ! Aedes novalbopictus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-281/282

AC   CVCL_Z911

RX   PubMed=608719;

RX   PubMed=791861;

CC   Group: Tick cell line.

CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).

OX   NCBI_TaxID=1134476; ! Haemaphysalis spinigera

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-304

AC   CVCL_Z912

RX   PubMed=791861;

CC   Group: Tick cell line.

CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).

OX   NCBI_TaxID=1256039; ! Haemaphysalis obesa

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-307

AC   CVCL_Z913

RX   PubMed=791861;

CC   Group: Tick cell line.

CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).

OX   NCBI_TaxID=34632; ! Rhipicephalus sanguineus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-308

AC   CVCL_Z914

RX   PubMed=791861;

CC   Group: Tick cell line.

CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).

OX   NCBI_TaxID=34632; ! Rhipicephalus sanguineus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-309

AC   CVCL_Z915

RX   PubMed=608719;

RX   PubMed=791861;

CC   Group: Tick cell line.

CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).

OX   NCBI_TaxID=1134476; ! Haemaphysalis spinigera

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-310

AC   CVCL_1B74

RX   PubMed=791861;

CC   Group: Tick cell line.

CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).

OX   NCBI_TaxID=1256039; ! Haemaphysalis obesa

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-311

AC   CVCL_Z916

RX   PubMed=791861;

CC   Group: Tick cell line.

CC   Miscellaneous: Cell line probably no longer available; no published report since 1976 (personal communication of Bell-Sakyi L.).

OX   NCBI_TaxID=1256039; ! Haemaphysalis obesa

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC-415

AC   CVCL_Z229

RX   DOI=10.1007/BF01666018;

RX   PubMed=16037617;

CC   Group: Insect cell line.

OX   NCBI_TaxID=69822; ! Culex bitaeniorhynchus

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ATC1

AC   CVCL_C755

RX   PubMed=15666850;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   ATCC-BXS0114

AC   CVCL_X497

DR   ATCC; ACS-1028

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   ATCC-BXS0115

AC   CVCL_0A06

DR   ATCC; ACS-1029

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   ATCC-BXS0116

AC   CVCL_0A07

DR   ATCC; ACS-1030

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   ATCC-BXS0117

AC   CVCL_0A08

DR   ATCC; ACS-1031

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   ATCC-BYS0110

AC   CVCL_X496

DR   ATCC; ACS-1024

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATCC-BYS0111

AC   CVCL_0A04

DR   ATCC; ACS-1025

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATCC-BYS0112

AC   CVCL_0A05

DR   ATCC; ACS-1026

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATCC-BYS0113

AC   CVCL_0A03

DR   ATCC; ACS-1027

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATCC-CYS0105

AC   CVCL_X498

DR   ATCC; ACS-1021

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 10,12

ST   D5S818: 9,13

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 9,11

ST   vWA: 17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATCC-DYP0250

AC   CVCL_C250

DR   ATCC; ACS-1004

DI   NCIt; C2975; Cystic fibrosis

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2381 ! CCD-186Sk

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATCC-DYP0530

AC   CVCL_C251

DR   ATCC; ACS-1014

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C254 ! ATCC-DYR0530

OI   CVCL_C255 ! ATCC-DYS0530

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATCC-DYP0730

AC   CVCL_C252

DR   ATCC; ACS-1003

DI   NCIt; C2993; Down syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2430 ! Detroit 532

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATCC-DYR0100

AC   CVCL_C253

DR   ATCC; ACS-1011

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 7,11

ST   D13S317: 11,13

ST   D16S539: 12

ST   D5S818: 11

ST   D7S820: 9,10

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 14,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3285 ! HFF-1

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATCC-DYR0530

AC   CVCL_C254

DR   ATCC; ACS-1012

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C251 ! ATCC-DYP0530

OI   CVCL_C255 ! ATCC-DYS0530

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATCC-DYS0100

AC   CVCL_X499

DR   ATCC; ACS-1019

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 7,11

ST   D13S317: 11,13

ST   D16S539: 12

ST   D5S818: 11

ST   D7S820: 9,10

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 14,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3285 ! HFF-1

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATCC-DYS0530

AC   CVCL_C255

DR   ATCC; ACS-1013

DI   NCIt; C26845; Parkinson's disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C251 ! ATCC-DYP0530

OI   CVCL_C254 ! ATCC-DYR0530

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATCC-HYR0103

AC   CVCL_C256

DR   ATCC; ACS-1007

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D5S818: 11,12

ST   D7S820: 7,10

ST   TH01: 6,9.3

ST   TPOX: 8,10

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATCC-HYS0103

AC   CVCL_X500

DR   ATCC; ACS-1020

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 12,13

ST   D5S818: 11,12

ST   D7S820: 7,10

ST   TH01: 6,9.3

ST   TPOX: 8,10

ST   vWA: 16,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATDC-5

AC   CVCL_3894

SY   ATDC5

DR   BTO; BTO:0001929

DR   CLO; CLO_0050536

DR   ECACC; 99072806

DR   Lonza; 227

DR   RCB; RCB0565

RX   PubMed=2201423;

RX   PubMed=23192741;

CC   Breed/subspecies: 129.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_8068 ! AT805

SX   Male

CA   Cancer cell line

//

ID   Atg3^(+/+)MEF

AC   CVCL_1T21

SY   Atg3 +/+ MEFs

DR   RCB; RCB3708

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   Atg3^(-/-)MEF

AC   CVCL_1T22

SY   Atg3 -/- MEFs

DR   RCB; RCB3709

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   Atg5^(+/+)MEF

AC   CVCL_0J74

DR   RCB; RCB2710

RX   PubMed=15525940;

CC   Breed/subspecies: C57BL/6 x 129/Sv.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   Atg5^(-/-)MEF

AC   CVCL_0J75

DR   RCB; RCB2711

RX   PubMed=15525940;

CC   Breed/subspecies: C57BL/6 x 129/Sv.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   ATH8

AC   CVCL_5206

SY   ATH-8

DR   ChEMBL-Cells; CHEMBL3307903

DR   ChEMBL-Targets; CHEMBL614273

RX   PubMed=2884263;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=ATH8

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   Athos

AC   CVCL_2298

SY   ATHOS

DR   CLO; CLO_0001763

DR   CLDB; cl294

DR   ECACC; 93122325

RX   PubMed=8514246;

RX   PubMed=1726925;

CC   Misspelling: 'ARTHOS' in PubMed=1726925.

OX   NCBI_TaxID=9823; ! Sus scrofa

HI   CVCL_2695 ! Porthos

CA   Finite cell line

//

ID   ATiPS-024

AC   CVCL_Y524

SY   AT-iPS-024

DR   SKIP; SKIP000392

RX   PubMed=24970375;

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2860 ! AT1OS

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATiPS-262

AC   CVCL_Y525

SY   AT-iPS-262

DR   SKIP; SKIP000393

RX   PubMed=24970375;

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2860 ! AT1OS

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATiPS-263

AC   CVCL_Y526

SY   AT-iPS-263

DR   SKIP; SKIP000394

RX   PubMed=24970375;

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2860 ! AT1OS

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATiPS-264

AC   CVCL_Y527

SY   AT-iPS-264

DR   SKIP; SKIP000395

RX   PubMed=24970375;

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2860 ! AT1OS

SX   Male

CA   Induced pluripotent stem cell

//

ID   ATL-10Y

AC   CVCL_A415

RX   PubMed=6193528;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ATL-16T

AC   CVCL_0147

SY   ATL16T

DR   MCCL; MCC:0000040

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ATL-17-2

AC   CVCL_6D78

RX   PubMed=2972890;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ATL-1K

AC   CVCL_A406

RX   PubMed=6193528;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ATL-2

AC   CVCL_8338

SY   ATL2

RX   PubMed=11021758;

RX   PubMed=11737246;

RX   PubMed=16314839;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ATL-2M

AC   CVCL_A407

RX   PubMed=6193528;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ATL-35T

AC   CVCL_8339

SY   ATL35T

RX   PubMed=16314839;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ATL-3I

AC   CVCL_A408

RX   PubMed=6193528;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ATL-43T

AC   CVCL_8340

SY   ATL43T

RX   PubMed=16314839;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ATL-4K

AC   CVCL_A409

RX   PubMed=6193528;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ATL-5S

AC   CVCL_A410

RX   PubMed=6193528;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ATL-5T

AC   CVCL_X530

DR   CGH-DB; 9029-4

RX   PubMed=9738977;

RX   PubMed=2890613;

RX   PubMed=10570904;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ATL-6A

AC   CVCL_A411

RX   PubMed=6193528;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ATL-7S

AC   CVCL_A412

RX   PubMed=6193528;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ATL-8K

AC   CVCL_A413

RX   PubMed=6193528;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ATL-9Y

AC   CVCL_A414

RX   PubMed=6193528;

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ATN-1

AC   CVCL_1073

DR   CLO; CLO_0050985

DR   BioSample; SAMN03472143

DR   ChEMBL-Cells; CHEMBL3308183

DR   ChEMBL-Targets; CHEMBL2366277

DR   Cosmic; 910687

DR   Cosmic-CLP; 910687

DR   GDSC; 910687

DR   GEO; GSM1669604

DR   RCB; RCB1440

RX   PubMed=3260813;

RX   PubMed=9738977;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 9,11

ST   D13S317: 11,12

ST   D16S539: 11

ST   D5S818: 10,13

ST   D7S820: 8

ST   TH01: 9

ST   TPOX: 9

ST   vWA: 14,18

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ATRFLOX

AC   CVCL_2299

SY   ATRFLOX [Mutatect]; ATRflox/-

DR   CLO; CLO_0001764

DR   EFO; EFO_0006535

DR   ATCC; CRL-2780

DR   BioSample; SAMN03472971

RX   PubMed=11721054;

RX   PubMed=25485619;

CC   Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 882; ATR.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

ST   Source(s): ATCC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 7,9

ST   D13S317: 10,12

ST   D16S539: 11,13

ST   D18S51: 16,17

ST   D21S11: 29,30

ST   D3S1358: 12,19

ST   D5S818: 10,12

ST   D7S820: 11,12

ST   D8S1179: 12,14

ST   FGA: 18,23

ST   Penta D: 9,13

ST   Penta E: 13,14

ST   TH01: 8,9

ST   TPOX: 8

ST   vWA: 17,22

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0291 ! HCT 116

SX   Male

CA   Cancer cell line

//

ID   ATRkd

AC   CVCL_7947

SY   GM847/ATRkd; ATR kinase dead

DR   BTO; BTO:0003696

RX   PubMed=9427750;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

DI   NCIt; C61255; Lesch-Nyhan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7908 ! GM00847

SX   Male

CA   Transformed cell line

//

ID   Atrt95

AC   CVCL_M154

RX   PubMed=9786246;

DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AtT-20

AC   CVCL_2300

SY   AtT20; AtT 20; ATT-20

DR   BTO; BTO:0001077

DR   CLO; CLO_0001765

DR   CLO; CLO_0001766

DR   CLDB; cl296

DR   ATCC; CCL-89

DR   BCRC; 60244

DR   CCRID; 3111C0001CCC000061

DR   CCRID; 3131C0001000800001

DR   ChEMBL-Cells; CHEMBL3307387

DR   ChEMBL-Targets; CHEMBL614523

DR   ECACC; 87021902

DR   IZSLER; BS TCL 149

DR   JCRB; JCRB9098

DR   KCB; KCB 93012YJ

DR   Lonza; 228

DR   TOKU-E; 566

DR   TOKU-E; 4284

RX   PubMed=13874682;

RX   PubMed=15541569;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/a/cell-lines-detail-156.html

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   AtT-20/D16-16

AC   CVCL_GZ35

DR   TOKU-E; 3994

RX   PubMed=2575458;

RX   PubMed=6250490;

RX   PubMed=6300893;

CC   Misspelling: 'AtT-20/D16-8' in TOKU-E 3994.

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4W08 ! AtT-20/D16v

CA   Cancer cell line

//

ID   AtT-20/D16v

AC   CVCL_4W08

SY   AtT-20/D-16v; AtT-20/D 16v; AtT20D16v

RX   PubMed=4312019;

RX   PubMed=6250490;

RX   PubMed=11383478;

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2300 ! AtT-20

CA   Cancer cell line

//

ID   AtT-20/D16v-F2

AC   CVCL_4109

SY   AtT20D16v-F2

DR   CLO; CLO_0001767

DR   CLDB; cl295

DR   ATCC; CRL-1795

DR   ECACC; 94050406

DR   IZSLER; BS TCL 144

DR   TOKU-E; 567

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4W08 ! AtT-20/D16v

CA   Cancer cell line

//

ID   AtT-20ins

AC   CVCL_1G40

SY   AtT-20 ins

RX   PubMed=1309953;

RX   PubMed=8325893;

RX   PubMed=8433987;

CC   Transfected with: HGNC; 6081; INS.

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2300 ! AtT-20

CA   Cancer cell line

//

ID   AtT-20ins4b/1

AC   CVCL_1G39

RX   PubMed=6317196;

CC   Transfected with: HGNC; 6081; INS.

CC   Breed/subspecies: LAF1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2300 ! AtT-20

CA   Cancer cell line

//

ID   AU-BEK

AC   CVCL_6533

SY   AUBEK; Aubek; Auburn University - Bovine Embryonic Kidney

DR   CLO; CLO_0001770

DR   CLDB; cl297

RX   PubMed=4798380;

WW   http://www.rccc.cytspb.rssi.ru/ecellbank/animal/aaubek.htm

OX   NCBI_TaxID=9913; ! Bos taurus

CA   Spontaneously immortalized cell line

//

ID   AU10000

AC   CVCL_2N35

DR   CLO; CLO_0011292

DR   Coriell; AU10000

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10001

AC   CVCL_2N36

DR   CLO; CLO_0011293

DR   Coriell; AU10001

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10002

AC   CVCL_2N37

DR   CLO; CLO_0011298

DR   Coriell; AU10002

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10003

AC   CVCL_2N38

DR   CLO; CLO_0011299

DR   Coriell; AU10003

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   AU10004

AC   CVCL_2N39

DR   CLO; CLO_0011296

DR   Coriell; AU10004

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10005

AC   CVCL_2N40

DR   CLO; CLO_0011297

DR   Coriell; AU10005

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10006

AC   CVCL_2N41

DR   CLO; CLO_0011300

DR   Coriell; AU10006

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10007

AC   CVCL_2N42

DR   CLO; CLO_0011330

DR   Coriell; AU10007

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10008

AC   CVCL_2N43

DR   CLO; CLO_0011329

DR   Coriell; AU10008

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10009

AC   CVCL_2N44

DR   CLO; CLO_0011328

DR   Coriell; AU10009

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10010

AC   CVCL_2N45

DR   CLO; CLO_0011327

DR   Coriell; AU10010

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10011

AC   CVCL_2N46

DR   CLO; CLO_0011326

DR   Coriell; AU10011

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10012

AC   CVCL_2N47

DR   CLO; CLO_0011325

DR   Coriell; AU10012

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10013

AC   CVCL_2N48

DR   CLO; CLO_0011324

DR   Coriell; AU10013

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10014

AC   CVCL_2N49

DR   CLO; CLO_0011323

DR   Coriell; AU10014

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10015

AC   CVCL_2N50

DR   CLO; CLO_0011322

DR   Coriell; AU10015

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10016

AC   CVCL_2N51

DR   CLO; CLO_0011321

DR   Coriell; AU10016

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10017

AC   CVCL_2N52

DR   CLO; CLO_0011338

DR   Coriell; AU10017

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10018

AC   CVCL_2N53

DR   CLO; CLO_0011340

DR   Coriell; AU10018

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10019

AC   CVCL_2N54

DR   CLO; CLO_0011339

DR   Coriell; AU10019

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10020

AC   CVCL_2N55

DR   CLO; CLO_0011335

DR   Coriell; AU10020

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10021

AC   CVCL_2N56

DR   CLO; CLO_0011334

DR   Coriell; AU10021

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10022

AC   CVCL_2N57

DR   CLO; CLO_0011337

DR   Coriell; AU10022

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10023

AC   CVCL_2N58

DR   CLO; CLO_0011336

DR   Coriell; AU10023

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10024

AC   CVCL_2N59

DR   CLO; CLO_0011332

DR   Coriell; AU10024

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10025

AC   CVCL_2N60

DR   CLO; CLO_0011331

DR   Coriell; AU10025

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10026

AC   CVCL_2N61

DR   CLO; CLO_0011333

DR   Coriell; AU10026

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10027

AC   CVCL_2N62

DR   CLO; CLO_0011306

DR   Coriell; AU10027

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10028

AC   CVCL_2N63

DR   CLO; CLO_0011305

DR   Coriell; AU10028

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10029

AC   CVCL_2N64

DR   CLO; CLO_0011304

DR   Coriell; AU10029

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10030

AC   CVCL_2N65

DR   CLO; CLO_0011303

DR   Coriell; AU10030

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10031

AC   CVCL_2N66

DR   CLO; CLO_0011310

DR   Coriell; AU10031

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10032

AC   CVCL_2N67

DR   CLO; CLO_0011309

DR   Coriell; AU10032

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10033

AC   CVCL_2N68

DR   CLO; CLO_0011308

DR   Coriell; AU10033

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10034

AC   CVCL_2N69

DR   CLO; CLO_0011307

DR   Coriell; AU10034

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10035

AC   CVCL_2N70

DR   CLO; CLO_0011302

DR   Coriell; AU10035

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10036

AC   CVCL_2N71

DR   CLO; CLO_0011301

DR   Coriell; AU10036

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10037

AC   CVCL_2N72

DR   CLO; CLO_0011320

DR   Coriell; AU10037

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10038

AC   CVCL_2N73

DR   CLO; CLO_0011313

DR   Coriell; AU10038

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10039

AC   CVCL_2N74

DR   CLO; CLO_0011312

DR   Coriell; AU10039

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10040

AC   CVCL_2N75

DR   CLO; CLO_0011315

DR   Coriell; AU10040

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10041

AC   CVCL_2N76

DR   CLO; CLO_0011314

DR   Coriell; AU10041

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10042

AC   CVCL_2N77

DR   CLO; CLO_0011317

DR   Coriell; AU10042

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10043

AC   CVCL_2N78

DR   CLO; CLO_0011316

DR   Coriell; AU10043

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10044

AC   CVCL_2N79

DR   CLO; CLO_0011319

DR   Coriell; AU10044

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10045

AC   CVCL_2N80

DR   CLO; CLO_0011318

DR   Coriell; AU10045

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10047

AC   CVCL_2N81

DR   CLO; CLO_0011311

DR   Coriell; AU10047

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10048

AC   CVCL_2N82

DR   CLO; CLO_0011370

DR   Coriell; AU10048

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10049

AC   CVCL_2N83

DR   CLO; CLO_0011369

DR   Coriell; AU10049

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10050

AC   CVCL_2N84

DR   CLO; CLO_0011367

DR   Coriell; AU10050

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10051

AC   CVCL_2N85

DR   CLO; CLO_0011368

DR   Coriell; AU10051

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10052

AC   CVCL_2N86

DR   CLO; CLO_0011365

DR   Coriell; AU10052

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10053

AC   CVCL_2N87

DR   CLO; CLO_0011366

DR   Coriell; AU10053

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10054

AC   CVCL_2N88

DR   CLO; CLO_0011363

DR   Coriell; AU10054

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10055

AC   CVCL_2N89

DR   CLO; CLO_0011364

DR   Coriell; AU10055

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10056

AC   CVCL_2N90

DR   CLO; CLO_0011361

DR   Coriell; AU10056

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10057

AC   CVCL_2N91

DR   CLO; CLO_0011362

DR   Coriell; AU10057

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10058

AC   CVCL_2N92

DR   CLO; CLO_0011378

DR   Coriell; AU10058

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10059

AC   CVCL_2N93

DR   CLO; CLO_0011380

DR   Coriell; AU10059

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10060

AC   CVCL_2N94

DR   CLO; CLO_0011379

DR   Coriell; AU10060

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10061

AC   CVCL_2N95

DR   CLO; CLO_0011374

DR   Coriell; AU10061

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10062

AC   CVCL_2N96

DR   CLO; CLO_0011375

DR   Coriell; AU10062

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10063

AC   CVCL_2N97

DR   CLO; CLO_0011376

DR   Coriell; AU10063

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10064

AC   CVCL_2N98

DR   CLO; CLO_0011377

DR   Coriell; AU10064

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10065

AC   CVCL_2N99

DR   CLO; CLO_0011371

DR   Coriell; AU10065

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10066

AC   CVCL_2P00

DR   CLO; CLO_0011372

DR   Coriell; AU10066

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10067

AC   CVCL_2P01

DR   CLO; CLO_0011373

DR   Coriell; AU10067

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10068

AC   CVCL_2P02

DR   CLO; CLO_0011350

DR   Coriell; AU10068

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10069

AC   CVCL_2P03

DR   CLO; CLO_0011349

DR   Coriell; AU10069

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10070

AC   CVCL_2P04

DR   CLO; CLO_0011348

DR   Coriell; AU10070

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10071

AC   CVCL_2P05

DR   CLO; CLO_0011347

DR   Coriell; AU10071

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10072

AC   CVCL_2P06

DR   CLO; CLO_0011343

DR   Coriell; AU10072

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10073

AC   CVCL_2P07

DR   CLO; CLO_0011344

DR   Coriell; AU10073

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10074

AC   CVCL_2P08

DR   CLO; CLO_0011341

DR   Coriell; AU10074

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10075

AC   CVCL_2P09

DR   CLO; CLO_0011342

DR   Coriell; AU10075

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10076

AC   CVCL_2P10

DR   CLO; CLO_0011345

DR   Coriell; AU10076

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10077

AC   CVCL_2P11

DR   CLO; CLO_0011346

DR   Coriell; AU10077

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10078

AC   CVCL_2P12

DR   CLO; CLO_0011356

DR   Coriell; AU10078

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10079

AC   CVCL_2P13

DR   CLO; CLO_0011358

DR   Coriell; AU10079

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10080

AC   CVCL_2P14

DR   CLO; CLO_0011357

DR   Coriell; AU10080

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10081

AC   CVCL_2P15

DR   CLO; CLO_0011360

DR   Coriell; AU10081

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10082

AC   CVCL_2P16

DR   CLO; CLO_0011359

DR   Coriell; AU10082

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10083

AC   CVCL_2P17

DR   CLO; CLO_0011351

DR   Coriell; AU10083

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10084

AC   CVCL_2P18

DR   CLO; CLO_0011352

DR   Coriell; AU10084

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10085

AC   CVCL_2P19

DR   CLO; CLO_0011353

DR   Coriell; AU10085

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10086

AC   CVCL_2P20

DR   CLO; CLO_0011354

DR   Coriell; AU10086

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10087

AC   CVCL_2P21

DR   CLO; CLO_0011355

DR   Coriell; AU10087

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10088

AC   CVCL_2P22

DR   CLO; CLO_0010938

DR   Coriell; AU10088

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10089

AC   CVCL_2P23

DR   CLO; CLO_0010939

DR   Coriell; AU10089

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10090

AC   CVCL_2P24

DR   CLO; CLO_0010940

DR   Coriell; AU10090

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10091

AC   CVCL_2P25

DR   CLO; CLO_0010934

DR   Coriell; AU10091

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10092

AC   CVCL_2P26

DR   CLO; CLO_0010935

DR   Coriell; AU10092

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10093

AC   CVCL_2P27

DR   CLO; CLO_0010936

DR   Coriell; AU10093

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10094

AC   CVCL_2P28

DR   CLO; CLO_0010937

DR   Coriell; AU10094

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10095

AC   CVCL_2P29

DR   CLO; CLO_0010926

DR   Coriell; AU10095

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10096

AC   CVCL_2P30

DR   CLO; CLO_0010929

DR   Coriell; AU10096

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10097

AC   CVCL_2P31

DR   CLO; CLO_0010931

DR   Coriell; AU10097

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10098

AC   CVCL_2P32

DR   CLO; CLO_0010959

DR   Coriell; AU10098

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10099

AC   CVCL_2P33

DR   CLO; CLO_0010960

DR   Coriell; AU10099

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10100

AC   CVCL_2P34

DR   CLO; CLO_0010957

DR   Coriell; AU10100

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10101

AC   CVCL_2P35

DR   CLO; CLO_0010958

DR   Coriell; AU10101

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10102

AC   CVCL_2P36

DR   CLO; CLO_0010955

DR   Coriell; AU10102

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10103

AC   CVCL_2P37

DR   CLO; CLO_0010956

DR   Coriell; AU10103

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10104

AC   CVCL_2P38

DR   CLO; CLO_0010953

DR   Coriell; AU10104

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10105

AC   CVCL_2P39

DR   CLO; CLO_0010954

DR   Coriell; AU10105

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10106

AC   CVCL_2P40

DR   CLO; CLO_0010949

DR   Coriell; AU10106

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10107

AC   CVCL_2P41

DR   CLO; CLO_0010951

DR   Coriell; AU10107

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10108

AC   CVCL_2P42

DR   CLO; CLO_0010966

DR   Coriell; AU10108

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10109

AC   CVCL_2P43

DR   CLO; CLO_0010967

DR   Coriell; AU10109

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10110

AC   CVCL_2P44

DR   CLO; CLO_0010968

DR   Coriell; AU10110

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10111

AC   CVCL_2P45

DR   CLO; CLO_0010969

DR   Coriell; AU10111

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10112

AC   CVCL_2P46

DR   CLO; CLO_0010970

DR   Coriell; AU10112

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10113

AC   CVCL_2P47

DR   CLO; CLO_0010961

DR   Coriell; AU10113

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10114

AC   CVCL_2P48

DR   CLO; CLO_0010962

DR   Coriell; AU10114

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10115

AC   CVCL_2P49

DR   CLO; CLO_0010963

DR   Coriell; AU10115

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10116

AC   CVCL_2P50

DR   CLO; CLO_0010964

DR   Coriell; AU10116

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10117

AC   CVCL_2P51

DR   CLO; CLO_0010965

DR   Coriell; AU10117

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10118

AC   CVCL_2P52

DR   CLO; CLO_0010975

DR   Coriell; AU10118

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10119

AC   CVCL_2P53

DR   CLO; CLO_0010976

DR   Coriell; AU10119

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10120

AC   CVCL_2P54

DR   CLO; CLO_0010979

DR   Coriell; AU10120

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10121

AC   CVCL_2P55

DR   CLO; CLO_0010980

DR   Coriell; AU10121

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10124

AC   CVCL_2P56

DR   CLO; CLO_0010977

DR   Coriell; AU10124

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10125

AC   CVCL_2P57

DR   CLO; CLO_0010978

DR   Coriell; AU10125

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10126

AC   CVCL_2P58

DR   CLO; CLO_0010973

DR   Coriell; AU10126

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10128

AC   CVCL_2P59

DR   CLO; CLO_0010974

DR   Coriell; AU10128

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10129

AC   CVCL_2P60

DR   CLO; CLO_0010971

DR   Coriell; AU10129

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10130

AC   CVCL_2P61

DR   CLO; CLO_0010972

DR   Coriell; AU10130

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10131

AC   CVCL_2P62

DR   CLO; CLO_0010987

DR   Coriell; AU10131

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10132

AC   CVCL_2P63

DR   CLO; CLO_0010986

DR   Coriell; AU10132

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10133

AC   CVCL_2P64

DR   CLO; CLO_0010985

DR   Coriell; AU10133

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10134

AC   CVCL_2P65

DR   CLO; CLO_0010984

DR   Coriell; AU10134

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10135

AC   CVCL_2P66

DR   CLO; CLO_0010983

DR   Coriell; AU10135

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10136

AC   CVCL_2P67

DR   CLO; CLO_0010982

DR   Coriell; AU10136

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10137

AC   CVCL_2P68

DR   CLO; CLO_0010981

DR   Coriell; AU10137

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10138

AC   CVCL_2P69

DR   CLO; CLO_0010990

DR   Coriell; AU10138

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10139

AC   CVCL_2P70

DR   CLO; CLO_0010989

DR   Coriell; AU10139

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10140

AC   CVCL_2P71

DR   CLO; CLO_0010988

DR   Coriell; AU10140

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10141

AC   CVCL_2P72

DR   CLO; CLO_0010996

DR   Coriell; AU10141

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10142

AC   CVCL_2P73

DR   CLO; CLO_0010995

DR   Coriell; AU10142

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10143

AC   CVCL_2P74

DR   CLO; CLO_0010998

DR   Coriell; AU10143

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10144

AC   CVCL_2P75

DR   CLO; CLO_0010997

DR   Coriell; AU10144

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10145

AC   CVCL_2P76

DR   CLO; CLO_0010992

DR   Coriell; AU10145

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10146

AC   CVCL_2P77

DR   CLO; CLO_0010991

DR   Coriell; AU10146

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10147

AC   CVCL_2P78

DR   CLO; CLO_0010994

DR   Coriell; AU10147

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10148

AC   CVCL_2P79

DR   CLO; CLO_0010993

DR   Coriell; AU10148

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10149

AC   CVCL_2P80

DR   CLO; CLO_0011000

DR   Coriell; AU10149

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10150

AC   CVCL_2P81

DR   CLO; CLO_0010999

DR   Coriell; AU10150

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10151

AC   CVCL_2P82

DR   CLO; CLO_0011010

DR   Coriell; AU10151

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10152

AC   CVCL_2P83

DR   CLO; CLO_0011004

DR   Coriell; AU10152

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10153

AC   CVCL_2P84

DR   CLO; CLO_0011003

DR   Coriell; AU10153

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10154

AC   CVCL_2P85

DR   CLO; CLO_0011002

DR   Coriell; AU10154

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10155

AC   CVCL_2P86

DR   CLO; CLO_0011001

DR   Coriell; AU10155

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10156

AC   CVCL_2P87

DR   CLO; CLO_0011008

DR   Coriell; AU10156

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10157

AC   CVCL_2P88

DR   CLO; CLO_0011007

DR   Coriell; AU10157

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10158

AC   CVCL_2P89

DR   CLO; CLO_0011006

DR   Coriell; AU10158

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10159

AC   CVCL_2P90

DR   CLO; CLO_0011005

DR   Coriell; AU10159

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10160

AC   CVCL_2P91

DR   CLO; CLO_0011009

DR   Coriell; AU10160

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10161

AC   CVCL_2P92

DR   CLO; CLO_0011019

DR   Coriell; AU10161

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10162

AC   CVCL_2P93

DR   CLO; CLO_0011020

DR   Coriell; AU10162

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10163

AC   CVCL_2P94

DR   CLO; CLO_0011012

DR   Coriell; AU10163

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10164

AC   CVCL_2P95

DR   CLO; CLO_0011011

DR   Coriell; AU10164

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10165

AC   CVCL_2P96

DR   CLO; CLO_0011014

DR   Coriell; AU10165

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10166

AC   CVCL_2P97

DR   CLO; CLO_0011013

DR   Coriell; AU10166

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10167

AC   CVCL_2P98

DR   CLO; CLO_0011016

DR   Coriell; AU10167

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10168

AC   CVCL_2P99

DR   CLO; CLO_0011015

DR   Coriell; AU10168

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10169

AC   CVCL_2Q00

DR   CLO; CLO_0011018

DR   Coriell; AU10169

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10170

AC   CVCL_2Q01

DR   CLO; CLO_0011017

DR   Coriell; AU10170

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10171

AC   CVCL_2Q02

DR   CLO; CLO_0011030

DR   Coriell; AU10171

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10172

AC   CVCL_2Q03

DR   CLO; CLO_0011029

DR   Coriell; AU10172

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10173

AC   CVCL_2Q04

DR   CLO; CLO_0011028

DR   Coriell; AU10173

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10174

AC   CVCL_2Q05

DR   CLO; CLO_0011026

DR   Coriell; AU10174

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10175

AC   CVCL_2Q06

DR   CLO; CLO_0011027

DR   Coriell; AU10175

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10176

AC   CVCL_2Q07

DR   CLO; CLO_0011024

DR   Coriell; AU10176

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10177

AC   CVCL_2Q08

DR   CLO; CLO_0011025

DR   Coriell; AU10177

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10178

AC   CVCL_2Q09

DR   CLO; CLO_0011022

DR   Coriell; AU10178

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10179

AC   CVCL_2Q10

DR   CLO; CLO_0011023

DR   Coriell; AU10179

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10180

AC   CVCL_2Q11

DR   CLO; CLO_0011021

DR   Coriell; AU10180

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10181

AC   CVCL_2Q12

DR   CLO; CLO_0011038

DR   Coriell; AU10181

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10182

AC   CVCL_2Q13

DR   CLO; CLO_0011037

DR   Coriell; AU10182

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10183

AC   CVCL_2Q14

DR   CLO; CLO_0011040

DR   Coriell; AU10183

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AU10184

AC   CVCL_2Q15

DR   CLO; CLO_0011039

DR   Coriell; AU10184

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU10185

AC   CVCL_2Q16

DR   CLO; CLO_0011033

DR   Coriell; AU10185

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C88412; Autism spectrum disorder

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AU565

AC   CVCL_1074

SY   AU-565; AU 565

DR   BTO; BTO:0004737

DR   CLO; CLO_0001769

DR   EFO; EFO_0001087

DR   ATCC; CRL-2351

DR   BioSample; SAMN03470878

DR   BioSample; SAMN03471449

DR   CCLE; AU565_BREAST

DR   ChEMBL-Cells; CHEMBL3308095

DR   ChEMBL-Targets; CHEMBL1075393

DR   Cosmic; 687462

DR   Cosmic; 910704

DR   Cosmic; 1136358

DR   Cosmic; 1176652

DR   Cosmic; 1309002

DR   Cosmic; 1995342

DR   Cosmic; 2165002

DR   Cosmic-CLP; 910704

DR   GDSC; 910704

DR   GEO; GSM344340

DR   GEO; GSM344390

DR   GEO; GSM847196

DR   GEO; GSM847451

DR   GEO; GSM843441

DR   GEO; GSM843442

DR   GEO; GSM886871

DR   GEO; GSM887936

DR   GEO; GSM1421428

DR   GEO; GSM1669605

DR   LINCS; 50091

RX   PubMed=17157791;

RX   PubMed=20070913;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://lincs.hms.harvard.edu/resources/reagents/icbp43/

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ICBP43 breast cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: MET genetic alteration cell panel (ATCC TCP-1036).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 9

ST   D18S51: 10,13

ST   D21S11: 30,30.2

ST   D3S1358: 17

ST   D5S818: 9,12

ST   D7S820: 9,12

ST   D8S1179: 11,12

ST   FGA: 20

ST   Penta D: 9,12

ST   Penta E: 10,11

ST   TH01: 8,9

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0033 ! SK-BR-3

SX   Female

CA   Cancer cell line

//

ID   AUC

AC   CVCL_AV82

SY   GM00328; GM0328; GM328

DR   CLO; CLO_0025538

DR   Coriell; GM00328

RX   PubMed=2475503;

RX   PubMed=2837086;

RX   PubMed=5231733;

DI   NCIt; C98944; Hereditary orotic aciduria

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   AV3

AC   CVCL_1904

SY   AV 3; AV-3

DR   CLO; CLO_0001771

DR   CLO; CLO_0001772

DR   CLO; CLO_0001773

DR   CLDB; cl298

DR   CLDB; cl299

DR   ATCC; CCL-21

DR   BioSample; SAMN03151665

DR   BioSample; SAMN03471470

DR   ECACC; 88102402

DR   IZSLER; BS CL 3

DR   KCLB; 10021

RX   PubMed=1246601;

RX   PubMed=20143388;

RX   PubMed=23925245;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=20143388).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Omics: Genome sequenced (low read coverage).

CC   Discontinued: KCLB; 10021; probable.

ST   Source(s): ATCC; ECACC

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 13.3 (ATCC)

ST   D13S317: 14 (ECACC)

ST   D16S539: 9,10

ST   D5S818: 11,12

ST   D7S820: 12

ST   TH01: 7

ST   TPOX: 8,12

ST   vWA: 16,18

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   Ava-BL

AC   CVCL_7174

RX   PubMed=12219084;

RX   PubMed=16051863;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   AVC1

AC   CVCL_W927

DR   Cosmic; 966783

DR   PRIDE; PXD002657

RX   PubMed=14677066;

RX   PubMed=26951071;

CC   Doubling time: 24 +- 1 hours (PubMed=14677066).

CC   Omics: Deep proteome analysis.

DI   NCIt; C6650; Ampulla of Vater adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AVE-115

AC   CVCL_4631

DR   CLO; CLO_0001774

DR   ATCC; CRL-6507

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6507; true.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Sex undetermined

CA   Undefined cell line type

//

ID   AVE,G

AC   CVCL_E463

SY   AVE, G

DR   dbMHC; 48481

DR   IHW; IHW9120

DR   IMGT/HLA; 10274

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl120.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   AVG-16

AC   CVCL_4110

DR   ECACC; 06062701

RX   PubMed=16848633;

RX   PubMed=26667575;

CC   Characteristics: Requires a media supplement called Ovagrow-S2A for continuous growth, but the company (Aivogen AG) producing this media does not exist anymore (personal communication from Horisberger M.A.).

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Female

CA   Conditionally immortalized cell line

//

ID   AVL

AC   CVCL_E464

SY   GM06823

DR   CLO; CLO_0036529

DR   Coriell; GM06823

DR   IHW; IHW0301

DR   IMGT/HLA; 10275

RX   PubMed=6417008;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl368.html

CC   Part of: 9th International Histocompatibility Workshop (9IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AVL/CTVM13

AC   CVCL_Z140

DR   TCB; 2961

RX   PubMed=15053931;

RX   PubMed=17662657;

RX   PubMed=21955214;

RX   PubMed=22743047;

CC   Group: Tick cell line.

OX   NCBI_TaxID=34610; ! Amblyomma variegatum

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   AVL/CTVM17

AC   CVCL_Z141

SY   AVL/CTVM 17

DR   ECACC; 94022811

DR   TCB; 2966

RX   PubMed=15053931;

RX   PubMed=17662657;

RX   PubMed=22743047;

CC   Group: Tick cell line.

CC   Discontinued: ECACC; 94022811; probable.

OX   NCBI_TaxID=34610; ! Amblyomma variegatum

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   AVO

AC   CVCL_EI30

DR   Cosmic; 1071907

DR   Cosmic; 1176607

DI   NCIt; C9039; Cervical carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AVS

AC   CVCL_HC48

RX   PubMed=15220421;

CC   Transformant: NCBI_TaxID; 10623; Cottontail rabbit papillomavirus (Kappapapillomavirus 2).

CC   Breed/subspecies: New Zealand white.

OX   NCBI_TaxID=9986; ! Oryctolagus cuniculus

CA   Transformed cell line

//

ID   AW 10498

AC   CVCL_D651

RX   PubMed=1691185;

CC   Doubling time: 52.2 hours (PubMed=1691185).

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AW 13516

AC   CVCL_D652

SY   AW13516

RX   PubMed=1691185;

CC   Doubling time: 35.5 hours (PubMed=1691185).

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AW 8507

AC   CVCL_D653

SY   AW8507

RX   PubMed=1691185;

CC   Doubling time: 31.9 hours (PubMed=1691185).

DI   NCIt; C4648; Tongue squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AW 9803

AC   CVCL_D654

RX   PubMed=1691185;

CC   Doubling time: 66 hours (PubMed=1691185).

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   AW-EBV-LCL

AC   CVCL_L559

DR   CLO; CLO_0051003

DR   BioSample; SAMN03472140

DR   RCB; RCB1437

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 9

ST   D5S818: 7,10

ST   D7S820: 11,12

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 17,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   Aw3.18.14

AC   CVCL_J158

DR   CLO; CLO_0001775

DR   ATCC; CRL-2826

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   AWCA

AC   CVCL_ER22

SY   CC-1

RX   PubMed=1691480;

RX   PubMed=8764055;

CC   Characteristics: Contains two copies of the HPV18 genome.

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AWELLS

AC   CVCL_E465

SY   Awells; WEL,AK; WEL, AK

DR   dbMHC; 48482

DR   ECACC; 94082236

DR   IHW; IHW9090

DR   IMGT/HLA; 11615

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl90.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AX0049

AC   CVCL_8B82

DR   ECACC; 91041816

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C126327; Usher syndrome type 1

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AX0050

AC   CVCL_8B83

DR   ECACC; 91041817

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   AX0051

AC   CVCL_8B84

DR   ECACC; 91041818

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AX0052

AC   CVCL_8B85

DR   ECACC; 91041819

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AY-11

AC   CVCL_6G28

SY   AY 11; AY11; T 11

RX   PubMed=7298281;

CC   Transformant: ChEBI; CHEBI:82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C60691; Rat urinary system neoplasms

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   AY-27

AC   CVCL_S825

SY   AY 27; AY27

RX   PubMed=2936252;

RX   PubMed=2981157;

RX   PubMed=7298281;

RX   PubMed=10574249;

RX   PubMed=20404568;

RX   PubMed=21424013;

CC   Transformant: ChEBI; CHEBI:82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C60691; Rat urinary system neoplasms

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   AY0001

AC   CVCL_8B86

DR   ECACC; 90112812

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   AY31

AC   CVCL_6G27

SY   AY 31; AY-31

RX   PubMed=7298281;

CC   Transformant: ChEBI; CHEBI:82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C60691; Rat urinary system neoplasms

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   AY32

AC   CVCL_6F40

SY   AY 32; AY-32

RX   PubMed=2981157;

RX   PubMed=7298281;

CC   Transformant: ChEBI; CHEBI:82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C60691; Rat urinary system neoplasms

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   AY33

AC   CVCL_6F41

SY   AY 33; AY-33

RX   PubMed=2981157;

RX   PubMed=7298281;

CC   Transformant: ChEBI; CHEBI:82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C60691; Rat urinary system neoplasms

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   AY34

AC   CVCL_6F42

SY   AY 34; AY-34

RX   PubMed=2981157;

RX   PubMed=7298281;

RX   PubMed=7448785;

CC   Transformant: ChEBI; CHEBI:82328; Nifurthiazole (N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide; FANFT).

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C60691; Rat urinary system neoplasms

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   AZ-521

AC   CVCL_2862

SY   AZ 521; AZ521

DR   CLO; CLO_0050792

DR   EFO; EFO_0002814

DR   BioSample; SAMN03151798

DR   CCLE; AZ521_STOMACH

DR   CGH-DB; 136-1

DR   ChEMBL-Cells; CHEMBL3307904

DR   ChEMBL-Targets; CHEMBL614274

DR   Cosmic; 877047

DR   Cosmic; 889108

DR   Cosmic; 918495

DR   Cosmic; 1066228

DR   Cosmic; 1077281

DR   Cosmic; 1187267

DR   Cosmic; 1482080

DR   Cosmic; 1518246

DR   Cosmic; 2484969

DR   GEO; GSM562393

DR   GEO; GSM827401

DR   GEO; GSM843443

DR   GEO; GSM886872

DR   GEO; GSM887937

DR   GEO; GSM1374397

DR   JCRB; JCRB0061

DR   RCB; RCB2087

DR   TKG; TKG 0185

RX   PubMed=15723654;

RX   PubMed=15767549;

RX   PubMed=22460905;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

WW   http://cell.brc.riken.jp/en/announcement/az521

CC   Problematic cell line: Contaminated. Shown to be a Hutu 80 derivative (see JCRB web site).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR45 cancer cell line panel.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): JCRB; RCB; TKG

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 8,11

ST   D16S539: 10,11

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   TH01: 7

ST   TPOX: 9,11

ST   vWA: 16,18

DI   NCIt; C7889; Duodenal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1301 ! HuTu 80

SX   Male

CA   Cancer cell line

//

ID   AZ-H3c

AC   CVCL_9480

SY   AZ-H3C

RX   PubMed=8609064;

DI   NCIt; C7889; Duodenal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2862 ! AZ-521

SX   Male

CA   Cancer cell line

//

ID   AZ-H6c

AC   CVCL_9479

SY   AZ-H6C

DR   Cosmic; 873709

DR   Cosmic; 888822

DR   Cosmic; 1122337

DR   Cosmic; 1187268

DR   Cosmic; 1518243

RX   PubMed=8609064;

DI   NCIt; C7889; Duodenal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2862 ! AZ-521

SX   Male

CA   Cancer cell line

//

ID   AZ303

AC   CVCL_D300

RX   PubMed=1423308;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D301 ! AZ382

OI   CVCL_D303 ! AZ390

SX   Female

CA   Cancer cell line

//

ID   AZ364

AC   CVCL_D302

RX   PubMed=1423308;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AZ382

AC   CVCL_D301

RX   PubMed=1423308;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D300 ! AZ303

OI   CVCL_D303 ! AZ390

SX   Female

CA   Cancer cell line

//

ID   AZ390

AC   CVCL_D303

RX   PubMed=1423308;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D300 ! AZ303

OI   CVCL_D301 ! AZ382

SX   Female

CA   Cancer cell line

//

ID   AZ402

AC   CVCL_D304

RX   PubMed=1423308;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AZ403

AC   CVCL_D305

RX   PubMed=1423308;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   AZ418

AC   CVCL_D306

RX   PubMed=1423308;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D307 ! AZ419

SX   Female

CA   Cancer cell line

//

ID   AZ419

AC   CVCL_D307

RX   PubMed=1423308;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_D306 ! AZ418

SX   Female

CA   Cancer cell line

//

ID   AZH

AC   CVCL_E466

DR   dbMHC; 48483

DR   ECACC; 94071439

DR   IHW; IHW9293

DR   IMGT/HLA; 10278

WW   http://bioinformatics.hsanmartino.it/ecbr/cl293.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   Azr3

AC   CVCL_5A63

RX   PubMed=954094;

CC   Selected for resistance to: ChEBI; CHEBI:6198; (S)-azetidine-2-carboxylic acid (AZCA).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_5A61 ! V79 A3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Azr7

AC   CVCL_5A64

RX   PubMed=954094;

CC   Selected for resistance to: ChEBI; CHEBI:6198; (S)-azetidine-2-carboxylic acid (AZCA).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_5A61 ! V79 A3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   B 5

AC   CVCL_J748

SY   B5; M-28

DR   CLO; CLO_0001818

DR   ATCC; HB-8453

RX   Patent=US4806628;

RX   Patent=US4808704;

CC   Discontinued: ATCC; HB-8453; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   B-1-A-2

AC   CVCL_U224

SY   B-1

DR   JCRB; JCRB0243

RX   PubMed=3643104;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   B-23

AC   CVCL_L176

DR   KCLB; 60049

CC   Breed/subspecies: BDIX.

DI   NCIt; C64069; Rat malignant glioma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   B-29

AC   CVCL_W182

DR   ATCC; CRL-6325

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6325; true.

CC   Breed/subspecies: C3H/Crgl.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5840 ! Mm5MT

SX   Female

CA   Cancer cell line

//

ID   B-3

AC   CVCL_6367

AS   CVCL_8482

SY   HLE-B3; HLE B-3; HLEB-3; HLEB3; HLEC-B3

DR   BTO; BTO:0002221

DR   CLO; CLO_0001812

DR   ATCC; CRL-11421

DR   BioSample; SAMN03471336

RX   Patent=US5643782;

RX   PubMed=8206728;

RX   PubMed=14578405;

CC   Transformant: Ad12-SV40.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11

ST   D16S539: 11,12

ST   D5S818: 9,11

ST   D7S820: 11

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 14,19

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   B-4

AC   CVCL_D851

RX   PubMed=8206728;

CC   Transformant: Ad12-SV40.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   B-63

AC   CVCL_4502

DR   CLO; CLO_0001824

DR   CLDB; cl5136

DR   ATCC; CRL-6326

DR   IZSLER; BS TCL 137

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6326; true.

CC   Breed/subspecies: C3H.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   B-CPAP

AC   CVCL_0153

SY   BCPAP

DR   BTO; BTO:0004736

DR   CLO; CLO_0001906

DR   MCCL; MCC:0000045

DR   BioSample; SAMN03471001

DR   CCLE; BCPAP_THYROID

DR   ChEMBL-Cells; CHEMBL3308356

DR   ChEMBL-Targets; CHEMBL1075394

DR   Cosmic; 755292

DR   Cosmic; 849970

DR   Cosmic; 924104

DR   Cosmic; 928836

DR   Cosmic; 931241

DR   Cosmic; 1084279

DR   Cosmic; 1162847

DR   Cosmic; 1237447

DR   Cosmic; 1239965

DR   Cosmic; 1280047

DR   Cosmic; 1507369

DR   Cosmic; 1533552

DR   Cosmic; 1536122

DR   Cosmic; 1889007

DR   Cosmic; 2036692

DR   Cosmic; 2054086

DR   Cosmic; 2319847

DR   Cosmic-CLP; 924104

DR   DSMZ; ACC-273

DR   GDSC; 924104

DR   GEO; GSM886875

DR   GEO; GSM887940

DR   GEO; GSM1669612

DR   NCBI_Iran; C596

RX   PubMed=15172756;

RX   PubMed=17725429;

RX   PubMed=17804723;

RX   PubMed=18713817;

RX   PubMed=19087340;

RX   PubMed=21868764;

RX   PubMed=22087789;

RX   PubMed=22460905;

RX   PubMed=23162534;

RX   PubMed=23833040;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~30 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=18713817; PubMed=21868764; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 12

ST   D16S539: 11,12

ST   D18S51: 13,17

ST   D19S433: 13.2,15

ST   D21S11: 30,31.2

ST   D2S1338: 18

ST   D3S1358: 16,17

ST   D5S818: 10,11

ST   D7S820: 10

ST   D8S1179: 12,13

ST   FGA: 20,23

ST   Penta D: 10,11

ST   Penta E: 5,12,17

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C4035; Thyroid gland papillary carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   B-HM8

AC   CVCL_J313

RX   PubMed=6819484;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   B-R18

AC   CVCL_CW55

DR   NCBI_Iran; H168

WW   http://www.neobiotechnologies.com/product_details.php?cat_no=355-MSM1-P0

CC   Monoclonal antibody target: UniProtKB; P25445; Human FAS/CD95.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   B-THP-1

AC   CVCL_0R19

DR   NIH-ARP; 9940-7

RX   PubMed=10721995;

RX   PubMed=14972530;

CC   Problematic cell line: Misidentified. Originally thought to be THP-1 (PubMed=10721995) but later shown to be a derivative of Raji (PubMed=14972530).

CC   Doubling time: ~20 hours (NIH-ARP).

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0511 ! Raji

SX   Male

CA   Cancer cell line

//

ID   B-THP-1/DC-SIGN

AC   CVCL_0R20

DR   NIH-ARP; 9941-52

RX   PubMed=14972530;

CC   Transfected with: HGNC; 1641; CD209.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0R19 ! B-THP-1

SX   Male

CA   Cancer cell line

//

ID   B-thy-ts.1

AC   CVCL_4W00

SY   Bthy.ts1

RX   PubMed=1374682;

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Conditionally immortalized cell line

//

ID   B/C.Li

AC   CVCL_6F06

SY   B/CLi; B/CL1

DR   ATCC; CRL-6328

DR   ATCC; CRL-6330

RX   PubMed=4366196;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6328; true.

CC   Discontinued: ATCC; CRL-6330; true.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   B/C.Ov

AC   CVCL_6F07

SY   B/C OV

RX   PubMed=4366196;

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Finite cell line

//

ID   B/C.Sk

AC   CVCL_7244

SY   B/C SK

DR   CLO; CLO_0001779

DR   CLDB; cl329

DR   ATCC; CRL-6329

DR   ECACC; 86111901

RX   PubMed=4366196;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6329; true.

CC   Discontinued: ECACC; 86111901; probable.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   B/C3T3.We

AC   CVCL_5925

DR   CLO; CLO_0001780

DR   ATCC; CRL-6327

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   B/CMBA.Ov

AC   CVCL_5926

DR   CLO; CLO_0001781

DR   ATCC; CRL-6331

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_S247 ! B/CMBA.Sp

OI   CVCL_S353 ! B/CMBA.Ut

SX   Female

CA   Finite cell line

//

ID   B/CMBA.Sp

AC   CVCL_S247

DR   ATCC; CRL-6332

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6332; true.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_5926 ! B/CMBA.Ov

OI   CVCL_S353 ! B/CMBA.Ut

SX   Female

CA   Finite cell line

//

ID   B/CMBA.Ut

AC   CVCL_S353

DR   ATCC; CRL-6333

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6333; true.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_5926 ! B/CMBA.Ov

OI   CVCL_S247 ! B/CMBA.Sp

SX   Female

CA   Finite cell line

//

ID   B/CWE

AC   CVCL_5927

DR   CLO; CLO_0001782

DR   ATCC; CRL-6334

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6334; true.

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   B0001

AC   CVCL_T365

DR   RCB; GMC0038

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Discontinued: RCB; GMC0038; probable.

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T364 ! A0001

SX   Female

CA   Transformed cell line

//

ID   B0006

AC   CVCL_T336

DR   CLO; CLO_0050480

DR   RCB; GMC0003

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   B0010

AC   CVCL_T353

DR   CLO; CLO_0050487

DR   RCB; GMC0025

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T352 ! A0010

SX   Female

CA   Transformed cell line

//

ID   B0022

AC   CVCL_T344

DR   CLO; CLO_0050494

DR   RCB; GMC0016

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T345 ! A0022

SX   Male

CA   Transformed cell line

//

ID   B0026

AC   CVCL_T363

DR   CLO; CLO_0050491

DR   RCB; GMC0035

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T362 ! A0026

SX   Female

CA   Transformed cell line

//

ID   B0031

AC   CVCL_T339

DR   CLO; CLO_0050481

DR   RCB; GMC0005

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T338 ! A0031

SX   Male

CA   Transformed cell line

//

ID   B0036

AC   CVCL_T349

DR   CLO; CLO_0050486

DR   RCB; GMC0023

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   B0042

AC   CVCL_T342

DR   CLO; CLO_0050482

DR   RCB; GMC0015

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T343 ! A0042

SX   Male

CA   Transformed cell line

//

ID   B0045

AC   CVCL_T361

DR   RCB; GMC0034

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   B0050

AC   CVCL_T355

DR   CLO; CLO_0050489

DR   RCB; GMC0030

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T354 ! A0050

SX   Female

CA   Transformed cell line

//

ID   B0055

AC   CVCL_T347

DR   CLO; CLO_0050483

DR   RCB; GMC0017

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T346 ! A0055

SX   Male

CA   Transformed cell line

//

ID   B0058

AC   CVCL_T358

DR   CLO; CLO_0050488

DR   RCB; GMC0029

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T357 ! A0058

SX   Male

CA   Transformed cell line

//

ID   B0072

AC   CVCL_T351

DR   CLO; CLO_0050485

DR   RCB; GMC0020

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T350 ! A0072

SX   Female

CA   Transformed cell line

//

ID   B0076

AC   CVCL_T356

DR   CLO; CLO_0050496

DR   RCB; GMC0026

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   B0078

AC   CVCL_T359

DR   CLO; CLO_0050490

DR   RCB; GMC0032

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   B0082

AC   CVCL_T334

DR   CLO; CLO_0050479

DR   RCB; GMC0001

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_T335 ! A0082

SX   Male

CA   Transformed cell line

//

ID   B0086

AC   CVCL_T360

DR   RCB; GMC0033

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   B0090

AC   CVCL_T348

DR   CLO; CLO_0050484

DR   RCB; GMC0019

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   B0096

AC   CVCL_T340

DR   CLO; CLO_0050495

DR   RCB; GMC0013

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

DI   NCIt; C3447; Werner syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   B02/GFP.2

AC   CVCL_5T77

RX   PubMed=11697798;

CC   Transfected with: UniProtKB; P42212; GFP.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C5214; Breast adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5T76 ! MDA-MB-231/B02

SX   Female

CA   Cancer cell line

//

ID   B0317047

AC   CVCL_8B87

DR   ECACC; 03091135

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   B0403741

AC   CVCL_8B88

DR   ECACC; 04022036

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   B1 [Mouse embryonal carcinoma]

AC   CVCL_1N71

SY   AG13176

DR   CLO; CLO_0022089

DR   Coriell; AG13176

RX   PubMed=2791350;

CC   Breed/subspecies: CBA.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_1N70 ! H6

CA   Cancer cell line

//

ID   B1 [Pig]

AC   CVCL_F749

RX   PubMed=2394515;

RX   PubMed=7951345;

CC   Transformant: NCBI_TaxID; 71581; Porcine endogenous retrovirus Tsukuba-1.

CC   Breed/subspecies: Miniature boar (d/d haplotype).

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Male

CA   Transformed cell line

//

ID   B1 NIH

AC   CVCL_J977

SY   B1

DR   ATCC; HB-10572

RX   Patent=US5612032;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   B1(NG)C39D

AC   CVCL_1N73

SY   AG13177

DR   CLO; CLO_0022090

DR   Coriell; AG13177

RX   PubMed=2321096;

RX   PubMed=2791350;

CC   Breed/subspecies: CBA.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_1N71 ! B1 [Mouse embryonal carcinoma]

CA   Cancer cell line

//

ID   B103

AC   CVCL_D538

SY   B-103

DR   BTO; BTO:0004397

DR   ChEMBL-Cells; CHEMBL3307905

DR   ChEMBL-Targets; CHEMBL614275

RX   PubMed=4151463;

WW   http://www.addexbio.com/productdetail?pid=25

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

CC   Breed/subspecies: BDIX.

DI   NCIt; C121567; Rat neuroblastoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Sex undetermined

CA   Cancer cell line

//

ID   B104 [Human lymphoma]

AC   CVCL_M498

DR   JCRB; JCRB0117

DR   JCRB; NIHS0144

RX   PubMed=1988498;

CC   Discontinued: JCRB; NIHS0144; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 10,11

ST   D16S539: 9,11

ST   D5S818: 11

ST   D7S820: 12

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C27907; B-cell neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   B104 [Rat neuroblastoma]

AC   CVCL_0154

SY   B-104

DR   CLO; CLO_0001783

DR   MCCL; MCC:0000046

DR   CLDB; cl4955

DR   ChEMBL-Cells; CHEMBL3307277

DR   ChEMBL-Targets; CHEMBL614025

DR   ICLC; ATL99008

RX   PubMed=284369;

RX   PubMed=4151463;

WW   http://www.protocol-online.org/biology-forums-2/posts/10837.html

CC   Transformant: ChEBI; CHEBI:23995; N-ethyl-N-nitrosourea (ENU).

CC   Misspelling: Occasionally '8104'.

CC   Breed/subspecies: BDIX.

DI   NCIt; C121567; Rat neuroblastoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Sex undetermined

CA   Cancer cell line

//

ID   B104-1-1

AC   CVCL_0396

DR   CLO; CLO_0001784

DR   CLDB; cl4944

DR   ATCC; CRL-1887

DR   BCRJ; 0272

DR   ICLC; ATL98015

RX   PubMed=6095109;

CC   Transfected with: RGD; 2561; Erbb2 (with E-661).

CC   Transformant: Activated Erbb2/neu.

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Transformed cell line

//

ID   B104-R3

AC   CVCL_2863

DR   JCRB; JCRB0117.1

CC   Discontinued: JCRB; JCRB0117.1; true.

DI   NCIt; C27907; B-cell neoplasm

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_M498 ! B104 [Human lymphoma]

SX   Male

CA   Cancer cell line



** -----------------------------------------------------------------------

**      CALIPHO group at the SIB - Swiss Institute of Bioinformatics

**      Geneva, Switzerland

** -----------------------------------------------------------------------

**

**   Description: References file for the Cellosaurus

**   Version: 24.0

**   Last update: 15-November-2017

**

** -----------------------------------------------------------------------


您正在向 biovector.net  发送关于产品 细胞株7-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。